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Functional Evaluation of the Peripheral Vasculature Using Magnetic Resonance
Imaging
Abstract
Akin to cardiac stress testing, functional integrity of the peripheral vasculature can be interrogated by
measuring the response to a stimulus. Recent reports suggest that the reactive hyperemia response, the
physiologic reaction following induced ischemia, is associated with disease presence, correlated with
disease severity, and may be a sensitive biomarker of pre-clinical disease.
In this dissertation, an innovative, interleaved magnetic resonance imaging method is developed, termed
Perfusion, Intravascular Venous Oxygen saturation, and T2* (PIVOT), which simultaneously measures
microvascular perfusion, venous oxygen saturation (SvO2), and the blood-oxygen-level dependent (BOLD)
signal. PIVOT is first applied in healthy subjects to demonstrate its ability to measure reactive hyperemia
response dynamics.
Next, reactive hyperemia perfusion is compared between the more temporally efficient pulsed arterial spin
labeling (PASL) used in PIVOT and the more recently developed and preferred method for the brain,
pseudo-continuous ASL (pCASL). Assessment of the impact of blood flow variability throughout the
ischemia-reperfusion paradigm on pCASL perfusion quantification is investigated. Then, both PASL and
pCASL sequences are used to measure reactive hyperemia perfusion in healthy subjects. No significant
differences were detected between perfusion measured with PASL or pCASL despite different labeling
strategies, temporal resolutions, and perfusion quantification models.
Subsequently, PIVOT is combined with a velocity-encoded dual-echo GRE to create an interleaved threeslice sequence that provides quantification of bulk blood flow in the arteries and veins in addition to the
traditional PIVOT measures. This new sequence, termed Velocity and PIVOT (vPIVOT) is used to
investigate the relationship of blood flow in the macro- and microvasculature and muscle oxygen
consumption during the transition from exercise to rest.
Finally, PIVOT is applied clinically in a cohort of patients with varying degrees of severity of peripheral
artery disease. Increasing disease severity was correlated with a prolongation of the hyperemic response
time, measured as a lengthening of time to peak perfusion, SvO2 washout time, and time to peak T2*. In
addition, peak perfusion and SvO2 upslope were significantly different between patients with PAD and
healthy controls. These results suggest the potential for PIVOT to evaluate disease severity and may
present a tool to assess response to therapeutic intervention.
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ABSTRACT

FUNCTIONAL EVALUATION OF THE PERIPHERAL VASCULATURE USING MAGNETIC
RESONANCE IMAGING

Erin K. Englund
Felix W. Wehrli, Ph.D.
Akin to cardiac stress testing, functional integrity of the peripheral vasculature can be interrogated
by measuring the response to a stimulus. Recent reports suggest that the reactive hyperemia
response, the physiologic reaction following induced ischemia, is associated with disease
presence, correlated with disease severity, and may be a sensitive biomarker of pre-clinical
disease.
In this dissertation, an innovative, interleaved magnetic resonance imaging method is developed,
termed Perfusion, Intravascular Venous Oxygen saturation, and T2* (PIVOT), which
simultaneously measures microvascular perfusion, venous oxygen saturation (SvO2), and the
blood-oxygen-level dependent (BOLD) signal. PIVOT is first applied in healthy subjects to
demonstrate its ability to measure reactive hyperemia response dynamics.
Next, reactive hyperemia perfusion is compared between the more temporally efficient pulsed
arterial spin labeling (PASL) used in PIVOT and the more recently developed and preferred
method for the brain, pseudo-continuous ASL (pCASL). Assessment of the impact of blood flow
variability throughout the ischemia-reperfusion paradigm on pCASL perfusion quantification is
investigated. Then, both PASL and pCASL sequences are used to measure reactive hyperemia
perfusion in healthy subjects. No significant differences were detected between perfusion
measured with PASL or pCASL despite different labeling strategies, temporal resolutions, and
perfusion quantification models.

v

Subsequently, PIVOT is combined with a velocity-encoded dual-echo GRE to create an
interleaved three-slice sequence that provides quantification of bulk blood flow in the arteries and
veins in addition to the traditional PIVOT measures. This new sequence, termed Velocity and
PIVOT (vPIVOT) is used to investigate the relationship of blood flow in the macro- and
microvasculature and muscle oxygen consumption during the transition from exercise to rest.
Finally, PIVOT is applied clinically in a cohort of patients with varying degrees of severity of
peripheral artery disease. Increasing disease severity was correlated with a prolongation of the
hyperemic response time, measured as a lengthening of time to peak perfusion, SvO2 washout
time, and time to peak T2*. In addition, peak perfusion and SvO2 upslope were significantly
different between patients with PAD and healthy controls. These results suggest the potential for
PIVOT to evaluate disease severity and may present a tool to assess response to therapeutic
intervention.
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CHAPTER 1: INTRODUCTION
1.1. Endothelial function and dysfunction
Blood flow is necessary to sustain life through the delivery of oxygen and nutrients
essential for cellular metabolism, and for the removal of waste products. In fact, every cell in the
body is separated from a blood vessel by only 1-3 cell widths, corresponding to approximately 40
micrometers (1). The regulation of blood flow to the tissue is a complex and dynamically
controlled process mediated in large part by the innermost layer of the artery, the vascular
endothelium (2) (Figure 1.1). Only one cell-layer thick, the endothelium is responsible for the
maintenance of vascular homeostasis and among other roles serves to regulate vascular tone,
the balance between vasodilation and vasoconstriction (3).

Figure 1.1. The structure and composition of the arterial wall. The endothelium is
the innermost layer of cells, and acts to maintain vascular tone and overall
homeostasis. In healthy vessels, shear stress due to blood flow in the artery
causes production and release of nitric oxide from the endothelial cells,
promoting vasodilation. Image from (4).
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To maintain appropriate vascular tone the endothelium produces and secretes several
vasoactive molecules, chief among which is nitric oxide (NO) (5). NO is a potent vasodilator
produced in the endothelium, which diffuses into the vascular smooth muscle, causing relaxation
and subsequent vasodilation. NO is produced enzymatically from L-arginine by endothelial NO
synthase (eNOS), which is activated by chemical (e.g. acetylcholine) or mechanical (e.g. shear
stress) stimulus. Balancing the effects of NO are factors that promote vasoconstriction including
endothelin-1 and angiotensin II, however in general the baseline state of endothelial function is
one of relative quiescence (6).
Endothelial dysfunction is the general term for the phenotypic presentation of a
vasoconstricted, pro-inflammatory, thrombogenic state, and is purported to be the earliest stage
of cardiovascular disease, preceding overt atherosclerotic plaque formation (3). A reduced
bioavailability or activity of NO is thought to be the predominant mechanism underlying
endothelial dysfunction, resulting in reduced vasodilation and delayed vascular reactivity (7).
Endothelial dysfunction exists in many diseases including diabetes (8) and atherosclerosis (9),
and is present in patients with significant risk factors for cardiovascular disease including aging
and hypertension (10). One disease in particular, peripheral artery disease (PAD) is the focus of
this thesis.

1.1.1. Peripheral artery disease
PAD, generally a manifestation of atherosclerosis in vessels supplying the lower limbs,
affects over 20% of the population over 70 and is thought to be the most under-diagnosed and
undertreated atherosclerotic disease (11-14). In PAD, atherosclerotic plaques develop at branch
points in the peripheral arteries, resulting in occlusions or stenoses that increase vascular
resistance and decrease blood flow to downstream skeletal muscle (15) (Figure 1.2). To meet
the baseline oxygen and nutrient delivery demands of the muscle, the decrease in arterial flow is
compensated by vasodilation of collateral arteries (15,16); but due to reduced vasoreactivity
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caused by endothelial dysfunction, the vasculature is unable to quickly respond to increases in
flow or metabolic demand (e.g. following a transient ischemia or during exercise). This creates an
oxygen supply-demand mismatch resulting in ischemia and causing patients to present with the
characteristic symptom of PAD – intermittent claudication, or pain on walking that is relieved by
rest (17,18).

Figure 1.2. The primary feature of PAD is the presence of atherosclerotic
plaques in the macrovasculature, which narrow the vessel lumen and reduce
blood flow to downstream skeletal muscle. Image from (19).
Although endothelial dysfunction coexists (20), the presence of occlusions or stenoses
due to atherosclerotic plaque formation in the peripheral circulation is the hallmark of PAD. In
fact, diagnosis, staging, and standard clinical monitoring of PAD are based solely upon
manifestations of macrovascular lesions even though those lesions are generally unchanged by
therapeutic interventions that improve patient symptomatology (21,22). Thus, the investigation of
endothelial function in patients with PAD may be critically important in yielding insight into the
mechanism of action of various therapeutic approaches, and providing better tools for clinical
monitoring.
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1.2. Measurement of endothelial function
1.2.1. Endothelium-dependent vasodilation
To investigate endothelial function, a state of increased blood flow known as hyperemia
is induced via a mechanical or chemical stimulus. In the coronary circulation, chemical stimulation
through intra-arterial infusion of acetylcholine is the typical method used to assess endothelial
function. Administration of acetylcholine triggers competing effects: vasoconstriction by activation
of the muscarinic receptors in vascular smooth muscle and vasodilation by stimulation of NO
production. Typically, the vasodilatory response dominates, however in the absence of the
endothelium or in endothelial dysfunction, vasoconstriction occurs (2). Quantitative angiography
can be used to directly measure the diameter of the artery before and after acetylcholine
administration, providing a measure of the coronary endothelial function.
In contrast to the coronary circulation, mechanical stimulation is feasible in the peripheral
circulation by means of temporary external compression of the arteries, commonly known as an
ischemia-reperfusion paradigm. In such a protocol, proximal arterial occlusion is sustained for
several minutes using either supra-systolic pressure applied via a sphygmomanometer cuff
secured around the subject’s arm or thigh, or invasively using an arterial clamp to occlude only
the vessel of interest. During the period of arterial occlusion, blood flow in the arteries, capillaries,
and veins is halted. The stagnant blood in the capillary bed is subjected to continued oxygen
extraction, though the oxygen diffusion gradient between blood and tissue decreases with
increasing ischemic duration. Additionally, there is local accumulation of vasodilators and a
reduction in arteriolar pressure, causing an overall decrease in vascular resistance.
Following cuff release, reactive hyperemia ensues with a transient surge of
macrovascular flow owing to the decrease in vascular resistance downstream. This increases
shear stress at the vessel wall, which activates eNOS, promoting NO production and release, and
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triggering arteriolar vasodilation (23). The return of blood flow causes an increase in perfusion,
delivering oxygenated blood to the ischemic tissue and driving out the accumulated vasodilators
and deoxygenated capillary blood. As deoxygenated blood exits the capillary bed, there is a
sharp decrease in intravascular venous oxygen saturation (SvO2) in the draining veins, which
then quickly recovers, reflecting the hyperperfusion of oxygenated arterial blood in the capillary
bed and the recovery of tissue oxygenation. SvO2 continues to rise and eventually surpasses the
baseline value during the time that blood velocity exceeds the oxygen extraction rate. The
kinetics and magnitude of the reactive hyperemic response provide insight about vascular
reactivity and endothelial function (24).
Alternatively, exercise can act as a stimulus to investigate the regulation of blood flow.
During exercise there is a decrease in tissue partial pressure of oxygen due to a local increase in
oxygen consumption. This triggers a metabolic response that demands increases of blood flow to
the muscle, resulting in additional capillary recruitment by relaxing the terminal arterioles. The
response to exercise is prolonged compared to the response elicited by transient ischemia due to
the increase in metabolic demand that accompanies exercise, which is not present in the
ischemic state. However, exercise is a subject-effort dependent paradigm and given the more
combined and coordinated effort to change the local blood flow, it maybe a more difficult
paradigm to investigate. In fact, Lopez et al recently investigated the response to ischemia
compared to exercise hyperemia and found that the microvascular perfusion response was more
repeatable following ischemia (25).

1.2.2. Early measures of endothelial function and control of muscle blood flow
The vital function of the endothelium in mediating vasodilation was not discovered until
Furchgott and Zawadzki’s seminal report in 1980 (2), and the specific role of NO was
subsequently uncovered by other investigators (5). Pivotal experiments were conducted prior to
that breakthrough to study the regulation of blood flow in the skeletal muscle capillary bed. Krogh,
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who later won the Nobel Prize in Physiology for his contribution to the field, suggested that under
baseline conditions not all capillaries are perfused, that is, blood flows only through select
channels within the capillary bed (26,27). Augmentation of flow largely served to increase the flow
through those open capillaries rather than through previously unopened channels (26,28). Followup studies found that in response to an increase in metabolic demand, recruitment of additional
capillaries was realized through vasodilation at the level of the terminal arteriole (29-31), however
this continues to be an active area of research (32).
Early studies in humans estimated muscle perfusion through venous occlusion
plethysmography (VOP), first described by Hewlett and van Zwaluwenburg in 1909 (33). In VOP,
relatively low external pressure is applied to the limb of interest, serving to occlude only venous
blood flow. The early rate of change of the distal limb circumference, measured via strain gauge,
relates to perfusion. VOP continues to be a standard to which other measures of perfusion are
compared, as it is noninvasive, inexpensive, and easy to combine with other methods (34).
However VOP-measured perfusion may overestimate skeletal muscle perfusion since its
measurement includes blood flow to the skin.
In 1964, Lassen, et al conducted the first study to specifically quantify skeletal muscle
perfusion during reactive hyperemia in healthy subjects and patients with PAD (35). Radioactive
133

Xe was injected locally into the muscle, and its clearance rate was measured both at baseline

and during reactive hyperemia. Perfusion at baseline was not significantly different between
healthy subjects and patients with PAD, but the hyperemia response was significantly reduced
and delayed in patients.
As understanding of the underlying physiology and technology advanced, the methods
developed to investigate vascular function expanded as well. Several imaging-based methods
have emerged for the measurement of endothelial function and vascular reactivity. Flow-mediated
dilation (FMD) of the brachial artery is perhaps the most common measure of macrovascular
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reactivity. To measure FMD, the diameter of the brachial artery is measured using Doppler
ultrasound before and after a period of ischemia. In patients with PAD, low brachial artery FMD
was associated with an increased risk for future cardiovascular event (36). However, the precise
measurement of the artery’s diameter can be difficult, requiring technical expertise, and in general
the brachial artery is spared from macrovascular atherosclerotic disease.
Other imaging-based approaches to investigate blood flow in skeletal muscle include
positron emission tomography (PET) or near infrared spectroscopy (NIRS). PET can quantify
perfusion through an adaptation of the Kety-Schmidt model (37) following injection of

15

O-water

(38). However, the obligatory injection of a radiotracer and the need for an on-site cyclotron for
15

O due to its short half-life has limited its application to only a few studies (38-42). Optical

imaging-based approaches on the other hand are noninvasive, the equipment is portable and
relatively inexpensive, and patient is not subjected to ionizing radiation. NIRS or near-infrared
diffusion correlation spectroscopy (DCS) have been used to measure relative changes in muscle
oxygenation and blood flow, respectively (43,44). However, the quantification of these physiologic
parameters requires complicated models and even so measurements are generally reported in
relative rather than absolute physiologic units. Furthermore, optical imaging is restricted to
relatively superficial structures therefore, while skeletal muscle is generally amenable,
measurements may be prone to error if there is substantial subcutaneous fat.
Magnetic resonance imaging (MRI) methods have also been utilized to investigate
vascular function. MRI is entirely non-invasive, produces tomographic images, does not require
injection of contrast, and does not expose the subject to ionizing radiation. MRI affords a wide
variety of different structural and functional contrasts, depending on the particular pattern of
magnetic field gradients and radiofrequency pulses, together known as a MRI pulse sequence.
Among the MRI methods is arterial spin labeling (ASL), a method for quantification of
perfusion in absolute physiologic units of mL blood per minute per 100 g of tissue. Only a few
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years after it was introduced by Detre, et al for the measurement of perfusion in the brain (45),
Toussaint and colleagues applied a variation of the technique for the measurement of skeletal
muscle perfusion during reactive hyperemia (46). Since then, several groups have continued to
investigate the post-ischemia perfusion response (25,34,47,48), and have additionally looked into
the response to exercise (25,49), hypoxia (50), various states of vascular filling (51), and in
disease states such as PAD (52).
Other MRI methods to assess vascular function include phase contrast flow
measurements (53-57), MR susceptometry for dynamic measurement of intravascular venous
oxygen saturation (SvO2) (58,59), and skeletal muscle blood-oxygen-level dependent (BOLD)
imaging, which uses relative changes in the effective transverse relaxation time (T2*) as a
surrogate for capillary bed oxygen content (60-65). Alterations in the dynamics of each of these
parameters have been associated with the presence of PAD during reactive hyperemia studies.
Patients exhibited a blunted and delayed hyperemic response in bulk arterial blood flow (66),
perfusion (52), dynamic SvO2 (67) , and T2* (68,69). The technical foundations of each of these
methods are described subsequently.

1.4. MRI measures of vascular function
1.4.2. Phase contrast MRI for quantification of flow
Unlike many of the previously mentioned responses, which are only altered due to
endothelial dysfunction in the post-stimulus state, the measurement of macrovascular blood flow
velocity provides insight into vascular health both at rest and during hyperemia. In young healthy
subjects, the baseline blood flow waveform of arteries in the peripheral circulation is triphasic,
with high velocity antegrade flow during the systolic phase of the cardiac cycle, followed by flow
reversal and then low velocity forward flow during diastole. In contrast to healthy subjects,
patients with PAD generally present with a monophasic flow waveform, where blood flow velocity
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drops during diastole, but remains antegrade throughout the entire cardiac cycle (70). In addition
to this baseline measurement of the arterial flow waveform, the dynamics of the arterial blood flow
response during reactive hyperemia or following exercise provide insight into endothelial function
and vascular reactivity, as pointed out earlier.

1.4.2.1. Quantification of blood flow velocity
Blood flow velocity can be quantified using phase-contrast MRI (53-55,71). Generally, the
temporal evolution of the phase of the MRI signal can be expressed as:
!

𝜑 𝑡 = 𝛾 𝑚! 𝑥! + 𝑚! 𝑣! + 𝑚! 𝑎! + ⋯
!

[1.1]

where γ is the gyromagnetic ratio, m0, m1, and m2 represent the zeroth, first, and second order
gradient moments, respectively (𝑚! =

!
𝐺
!

𝜏 𝜏 ! 𝑑𝜏 and G is the gradient amplitude at time, t), x0

is the position of the spin, v0 is the velocity, and a0 represents acceleration. The relationship can
be expanded to include higher order time derivatives of position such as jerk, however these
terms are generally disregarded.
By using bipolar gradients, it is possible to create a situation with m0 = 0, but a non-zero
m1. In this case, stationary spins will have complete phase restoration, but moving spins will
accumulate phase as a function of velocity (Figure 1.3).
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Figure 1.3. Diagram showing the effect of bipolar gradients on stationary and
moving spins. The phase evolution of stationary spins is shown in the center, and
that of moving spins is shown in bottom. Bipolar gradients are balanced, having
no net area and therefore imparting no residual phase onto stationary spins.
However there is a non-zero first gradient moment, causing accumulation of
phase in moving spins.

In this special situation, moving spins will accrue phase simply as: 𝜑 𝑡 = 𝛾𝑚! 𝑣. In
phase contrast MRI, the first gradient moment is changed (typically toggled) between otherwise
identical image acquisitions. The phase difference between these two images attenuates phase
variation from background field gradients and accentuates the phase accrual due to motion. The
range of velocities that can be measured without phase wrapping is given by a user-defined
parameter related to the difference in m1 between the two acquisitions, the velocity encoding
(VENC) as:
𝑉𝐸𝑁𝐶 =

!

[1.2]

!∙!!!

Thus for toggled gradients, Δm1 = m1 – (-m1) = 2m1.

10

1.4.2.2. Gated and ungated methods
Velocity maps can be acquired in several different forms. By gating the phase contrast
acquisition to the electrocardiogram, several images can be reconstructed at different time points
in the cardiac cycle, providing cine images of blood flow throughout the cardiac cycle (72). Image
acquisition generally takes several seconds to minutes depending on the apparent temporal
resolution desired, as k-space data are acquired over several heartbeats and synthesized
together to create images of a single cardiac phase. Furthering this technique, velocity can be
resolved in 3 dimensions along with 3-dimensional spatial encoding to create 4D flow images
(73,74).
If the acquisition is not gated to the cardiac cycle, the velocity will be weighted by the
phase of the cardiac cycle during the acquisition of the center portion of k-space. Alternatively,
ungated

projection

phase

contrast

can

generate

time-resolved

beat-to-beat

velocity

measurements (56,57). In Langham, et al’s approach to quantify velocity via k-space projections
a fully phase encoded reference image is first obtained, followed by acquisition of only the
centerline of k-space (k-space projection) (57). The reference image is used to create a static
tissue k-space projection by masking out the vessels of interest, then taking the inverse Fourier
transform and isolating the center k-space line (ky=0). This static tissue k-space projection is
subtracted from every dynamically acquired velocity-encoded projection to isolate blood signal.
The phase difference between adjacent positive and negative velocity-encoded projections is
computed and the average velocity across the vessel of interest can be quantified temporal
resolution equal to the pulse sequence repetition time (TR), using a temporal window of two TRs.
Reactive hyperemia bulk flow or blood flow velocity time courses can provide insight into
the vascular reactivity and endothelial function (75). Parameters of interest include the time to
peak flow and the duration of forward flow, which are increased in the presence of PAD (66).
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1.4.3. Arterial spin labeling for perfusion quantification
ASL is a well-established method for noninvasive perfusion imaging (45,76-79).
Several variations of ASL exist, employing various labeling strategies, but generally perfusion is
quantified by pairwise subtraction between two images – one acquired after magnetically-labeling
the inflowing arterial blood (label) and an otherwise identical image without the label (control).
The resultant signal difference cancels out the contribution from static tissue, leaving behind a
signal that is related to the amount of perfusion, that is microvascular flow and exchange between
blood water and tissue water, that occurred during the time between the label and image
acquisition (Figure 1.4). This signal can be converted into perfusion in units of mL/min/100g
through application of various models that describe the exchange between arterial blood water
and tissue water (34,47,80,81).

Figure 1.4. General experimental setup for ASL MRI-based perfusion measurement. Identical
images are acquired with or without magnetically labeling arterial blood in the label and control
conditions, respectively. Static tissue signal is unchanged between these two images, thus
subtraction cancels out its contribution, leaving behind only the signal from exchange of blood
and tissue water during the post labeling delay.

The ASL labeling method scan be divided into two general categories: those that label
by flow-driven adiabatic inversion of blood as it passes through a labeling plane, as in continuous
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ASL (CASL) or pseudo-continuous ASL (pCASL), or those that use spatially selective inversion of
blood as in pulsed ASL (PASL) (Figure 1.5). Skeletal muscle perfusion during hyperemia has
been quantified with all of these methods (25,34,47,48), and there are benefits and drawbacks to
each. CASL and pCASL methods utilize a long pulse or series of pulses to achieve inversion,
thereby reducing labeling efficiency to approximately 85% (82) and limiting temporal resolution to
6-8 seconds (47,48,52). CASL or pCASL methods do offer an increase in theoretical signal-tonoise ratio compared to PASL as the labeled blood water spins accumulate in the tissue
throughout the longer labeling duration (83). PASL on the other hand uses a single RF pulse for
nearly instantaneous and complete inversion, allowing perfusion measurement at a temporal
resolution of up to 2 second (34).
Both PASL and pCASL or CASL methods have an unavoidable post-labeling delay
(PLD). The PLD is dead time between the arterial labeling pulse and the image acquisition
required to allow the transit of blood from the labeling location into the imaging slice location. The
temporal resolution of PASL is largely limited by the duration of the PLD. For pCASL and CASL,
the labeling duration and PLD are typically approximately the same at about 1-2 seconds each
(81).
Due to the transient nature of the hyperemic response, high temporal resolution
sampling of the time course is necessary. Furthermore, there is baseline signal variation over the
course of the ischemia reperfusion experiment due to the changing oxygen saturation and
vascular volume in the capillaries causing changes in the BOLD signal. To correct for the
baseline signal variation, temporal matching of the label and control datasets is performed by
linear interpolation of the control dataset (47). Interpolation works well when the signal change is
negligible or linear between the time points, however when signal variation changes rapidly, as
seen immediately following cuff release, linear temporal matching does not compensate for the
dynamic changes. Given that the offset between label and control images is approximately 3 – 4
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seconds in CASL or pCASL, and only 1 – 1.5 seconds in PASL, the BOLD signal changes are
more accurately adjusted in PASL (84).

Figure 1.5. Description and location of label and control locations in CASL,
pCASL, and PASL experiments. In CASL and pCASL, flow-driven adiabatic
inversion causes blood in the artery to be inverted as it passes through the
proximal labeling plane. In the control condition for CASL, the labeling plane is
located distal to the imaging slice location. For the pCASL control condition, the
location of the labeling plane remains unchanged, but no net labeling of blood is
achieved. In contrast, the label condition of the PASL sequence is a sliceselective inversion, causing inversion of tissue, but inflowing blood is uninverted.
In the control condition of PASL both the inflowing blood and tissue signal are
inverted.

1.4.3.1. Continuous and pseudo-continuous ASL
In CASL, inflowing arterial blood is selectively inverted in the label condition through flowdriven adiabatic inversion (85), in which a continuous low B1 field is played alongside a constant
amplitude gradient to drive spins moving perpendicularly through the labeling plane to the
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negative Z axis (Figure 1.6a). An adiabatic inversion is achieved in the presence of a constant
gradient and B1 field, as long as the velocity of the spin meets the adiabatic condition:
!
!!

≪

!"
!!""

≪ 𝛾 𝐵!""

[1.4]

where T2 is the transverse relaxation time of blood water protons, v is the velocity of the spin, G is
the average gradient amplitude, Beff is the effective magnetic field, and γ is the proton
gyromagnetic ratio. Implications of this will be further discussed in Chapter 3.
Labeling generally lasts one to two seconds. Current MRI transmit coils are incapable of
playing out such a long continuous B1 field, thus pCASL was introduced as an adaptation of
CASL (82). pCASL also relies on flow-driven adiabatic inversion, but rather than continuous
radiofrequency (RF) excitation for the duration of a second or so, the excitation period is broken
up into a train of short RF pulses along with oscillating gradients with a non-zero net amplitude
are used (Figure 1.6b) to label blood.
To prevent errors due to magnetization transfer effects, the low flip angle RF pulse or
pulses must be matched between the label and control image acquisitions (86). In CASL, the
simplest option uses gradients of opposed polarity or RF of opposite phase; either option causes
the labeling plane to be distal to the imaging location (Figure 1.6d). For the control condition in
pCASL, spins remain uninverted through application of similar RF pulses as in pCASL labeling,
but alternating in phase by 180°, and zero net gradient amplitude (Figure 1.6e) (82), thereby
imparting no net excitation.
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Figure 1.6. Pulse sequence diagrams of label and control schemes for CASL,
pCASL, and PASL. Flow-driven adiabatic inversion is used to label arterial blood
water spins in both CASL and pCASL. In the control condition, spins in inflowing
blood remain unperturbed either by labeling distal to the imaging slice (as in
CASL) or by producing no net excitation (as in pCASL). Spatially selective or
non-selective adiabatic inversion pulses are used for PASL label and control,
respectively.

1.4.3.2. Pulsed ASL
There are several variants of pulsed arterial spin labeling. The method that has been
most widely applied for skeletal muscle perfusion is Flow-Alternating Inversion Recovery (FAIR)
or offshoots of that method (25,34,49,51). In contrast to CASL and pCASL, PASL labeling is
achieved via application of a single spatially-selective inversion pulse, meaning that the duration
of the label or control module is much shorter, spins are inverted regardless of the flow velocity,
and the transit distance between the locations of the label and the image acquisition is generally
much smaller. Thus, PASL methods have faster labeling and thus higher potential temporal
resolution, and higher and more consistent labeling efficiency.
In FAIR (77) a RF pulse inverts the magnetization either slice-selectively (SS) for the
label condition, or non-selectively (NS) for the control condition (Figure 1.6 c, f). Thus for the
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label condition, the tissue signal is recovering from inversion, but inflowing blood remains
uninverted, and in the control condition both the inflowing blood and tissue are recovering from
inversion. Saturation Inversion Recovery, a method developed for the measurement of skeletal
muscle perfusion by Raynaud, et al (34) uses the same control and label conditions as in FAIR,
and additionally includes a slice-selective saturation pulse after each imaging readout to ensure
presence of the same initial magnetization in each dynamic acquisition.

1.4.3.3. Quantification of perfusion
To determine perfusion in physiologic units, several models have been proposed that
derive from the general solution to the Bloch equation for longitudinal magnetization of blood
including a term for inflow and outflow of blood, originally described by Detre, et al (45):
!!!
!"

=

!! !!!
!!

+ 𝑓 𝑀! − 𝑀!

[1.5]

where Mz is the longitudinal magnetization of water in tissue, Ma is that of arterial blood water, Mv
!

is that of venous blood water (𝑀! = , where λ is the tissue partition coefficient), T1 is the
!

relaxation time of tissue, and f represents perfusion.
Assuming a one-compartment model for blood (e.g. blood water is delivered and
accumulates in tissue), pCASL perfusion can be quantified as described by Buxton, et al (80) as:
!"#

𝑓=

!∙ !!"#$%"& !!!"#$! ∙! !!,!"##$
!∙!∙!!,!"##$ ∙!!"#$%"& ∙ !!!

!!
!!,!"##$

[1.6]

where PLD represents the post labeling delay – the time between the end of the labeling period
and image acquisition, T1,blood is the longitudinal relaxation time of blood, α is the labeling
efficiency, and τ is the labeling duration. An alternate form of this model can be used to quantify
perfusion using the SATIR PASL sequence (34). Using a similar one-compartment model and

17

assuming the T1 of blood and tissue can be approximated as equal, perfusion can be quantified
as:

𝑓=

!
!"#

∙ ln

!!"#$! !!!"#$%"&
!!"#$! !!!"#$%"&

!"#

∙ 1 − 𝑒 !!,!"##$ + 1

[1.7]

In the brain the interest is generally in high accuracy measurement of spatially
resolved perfusion, therefore several repeats are averaged to create a voxelwise map of
perfusion. In skeletal muscle, although spatial localization of the signal is important, the interest is
generally in the dynamic measurement of perfusion changes over time. Thus, each label and
control image pair is used to calculate perfusion, yielding time-resolved perfusion in muscles of
interest. In reactive hyperemia experiments, the time course is analyzed to determine the speed
of response, measured as the time to peak perfusion, and the response magnitude, measured as
the peak perfusion. Prior studies have uncovered an association between peak perfusion and
PAD disease presence and severity, showing a decrease in peak perfusion with the presence of
PAD and a further decrease with increasing disease severity. A similar trend was reported for the
time to peak perfusion – with increasing disease severity there was an increase in the time to
peak perfusion (52).

1.4.4. Dynamic oximetry
SvO2 is an important physiologic parameter, providing information about oxygen
utilization in tissue (58,87). During the ischemia reperfusion paradigm, supra-systolic pressure
halts arterial inflow and oxygen extraction continues in the stationary blood of the capillary bed,
but due to the stagnation of blood flow there is no observed change in SvO2 of the draining vein.
Upon cuff release, the hyperemic arterial inflow drives deoxygenated blood in the capillary bed
into the collecting veins, causing the measured SvO2 to drop sharply. This response is followed
by an overshoot as the increased flow velocity exceeds the maximum oxygen extraction rate. The
SvO2 then normalizes back to the baseline value. Oxygen extraction only occurs in the capillary
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bed, thus the dynamic measurement of SvO2 allows intravascular blood to act as an endogenous
tracer, providing information about endothelial function and vascular reactivity (66,67,75,88).
There are two main methods that have been introduced and reduced to practice for
measurement of oxygen saturation in the large draining veins. These are MR susceptometrybased oximetry (58,87), and T2-based oximetry (89), such as T2 relaxation under spin tagging,
commonly called TRUST (90) or projection T2 (91). The T2-based oximetry method requires a
sequence-specific calibration between the measured T2 and %HbO2 (92). On the other hand, MR
susceptometry quantifies SvO2 by modeling the relationship between the venous oxygen
saturation and the induced magnetic field shift (58,87). Thus susceptometry-based oximetry is
more limited in the geometry of vessels to which it can be applied, but does not require any
sequence-specific calibration. For applications in skeletal muscle, MR susceptometry is preferred
owing to the fact that the vessels are generally long and oriented parallel to the main magnetic
field, thus an analytical solution can equate the MRI measurement to SvO2. Furthermore, MR
susceptometry has higher feasible temporal resolution than T2-based methods, which typically
require a lengthy T2 prep and image acquisition. Maximum temporal resolution of T2-based
oximetry is limited to 12 seconds (93), while a temporal sampling rate exceeding 2 seconds can
be obtained with MR susceptometry (94).

1.4.4.1. Susceptometry-based oximetry
MR susceptometry-based oximetry is a recently developed method for quantifying SvO2,
measured in units of percent-oxygenated hemoglobin (%HbO2) (58,87). Due to the different
electron spin configurations of the Fe

2+

heme iron in the oxygenated versus deoxygenated state

(95), the magnetic properties of arterial and venous blood differ. Specifically, deoxyhemoglobin is
paramagnetic thus creating a magnetic susceptibility difference between it and diamagnetic
oxyhemoglobin and tissue. The susceptibility difference (Δχ) is related to the content of
deoxygenated hemoglobin in the blood as:
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∆𝜒 = ∆𝜒!" Hct 1 − SvO!

[1.8]

where Δχdo represents the susceptibility difference between fully oxygenated and fully
deoxygenated blood (Δχdo = 4π·0.27 ppm (SI units) (96,97)) and Hct is the hematocrit. The
susceptibility difference induces a local magnetic field ΔB in the draining vein relative to the
tissue, which, by modeling the vein as a long paramagnetic cylinder, can be described as:
!

∆B = ∆𝜒 B! 3cos ! 𝜃 − 1

[1.9]

!

where B0 is the main magnetic field strength, and θ is the angle of the vessel with respect to B0.
The incremental field ΔB can be determined by subtracting the phase accumulation of the MRI
signal in surrounding tissue from that inside the vein (Δφ) as:
∆ϕ = γ ∆B ∆TE

[1.10]

where the phase is measured from successive echoes separated in echo time by ΔTE (Figure
1.7). Combining equations 1.8-1.10, one can relate the intra/extravascular inter-echo phase
difference to SvO2 as:

SvO! = 1 −

!

!!

!!"
! !!!" !! !"#! !!! !

× 100

[1.11]

It has been shown that for small angles, the induced field outside of the vessel is approximately
homogeneous and independent of the susceptibility difference between the vein and tissue (98).
Therefore SvO2 can be measured using a field-mapping sequence, such as a multi-echo
gradient-recalled echo (GRE). With this technique, one can quickly, directly, and noninvasively
quantify intravascular SvO2 at high-temporal resolution. Due to inhomogeneities in the main
magnetic field, background phase accumulation can occur. In the image processing of multi-echo
GRE oximetry data, the background phase modulation is fitted and subtracted out as described
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by Langham, et al (99).

Figure 1.7. Diagram depicting the vein as a long, relatively parallel,
paramagnetic cylinder. The inter-echo phase accrual of intravascular blood (φ i) is
compared to that of background tissue (extravascular phase, φ e). The difference
between intra- and extravascular phase accrual is proportional to the incremental
magnetic field shift inside the vessel, which can be related to susceptibility and
hence SvO2.

Washout time (time to minimum SvO2), upslope – representing the rate of resaturation
(maximum slope during recovery), and overshoot (peak SvO2 minus baseline SvO2) can be
extracted from the SvO2 time course data. These metrics reflect the reactivity of the microvessels
to NO-mediated vasodilation. Langham et al revealed an association between alterations in the
SvO2 time course-derived metrics in the femoral vein and the presence of PAD (66,67).
Compared to age-matched healthy controls and young healthy subjects, patients with PAD had a
longer washout time, diminished upslope, and lower overshoot, suggesting endothelial
dysfunction.

1.4.5. BOLD MRI
In the microvasculature, as in the large veins, the paramagnetism of deoxyhemoglobin
causes inhomogeneities in the local magnetic field. Because the microvessels are small
compared to the MR imaging resolution, it is not possible to directly measure a change in signal
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phase as was described above for MR susceptometry. However, changes in the concentration of
deoxyhemoglobin will modify the local magnetic field to cause incoherent phase accrual, resulting
in intravoxel phase dispersion, which causes the MRI magnitude signal to decay more rapidly
(60,61). This can be measured as a reduction in the effective transverse relaxation time, T2*, and
represents the contrast mechanism commonly known as the BOLD response. The BOLD signal
originates not only from changes in blood oxygen level, it is also sensitive to changes in
perfusion, cellular pH, vessel diameter, and vessel orientation (100-103). It has been postulated,
however, that the skeletal muscle BOLD signal primarily results from changes in the
concentration of deoxyhemoglobin in the capillary bed (103).
BOLD imaging has been extensively applied for functional activation studies in the brain,
and can additionally be used to investigate activation of other organs including skeletal muscle.
Changes in T2* in response to an ischemia-reperfusion paradigm can serve as a relative marker
of tissue oxygenation (104). The multifactorial contrast mechanism and the fact that the
measured response is relative, rather than in physiologic units, however, can make the
interpretation of the BOLD signal more complicated than perfusion or dynamic SvO2.
Quantification of T2* can be achieved by fitting signal intensity (SI) data from a multi-echo
gradient-recalled echo acquisition to a monoexponential function: 𝑆 TE = 𝑆! 𝑒

!!"

!! ∗

where TE is

the echo time of the acquisition. Prior studies have shown the utility of investigating dynamic
skeletal muscle BOLD during exercise (105-107), ischemia (69), reactive hyperemia (46), and in
disease states (68,69). Important metrics that may provide information about vascular function in
reactive hyperemia experiments include relative T2* maximum and the time to maximum T2*.
Previous work by Ledermann and colleagues showed that patients with PAD had a reduction in
the peak T2* and a prolongation in the time to peak T2* compared to healthy subjects (68).
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1.4.6. Combined measures of flow and oxygenation
The combination of measures of flow and oxygenation can provide additional information
regarding the vascular function. Some MRI protocols explored the combination of imaging and
spectroscopy to assess either metabolism directly, or tissue oxygen saturation. Specifically, a
method proposed by Richardson, et al combined the measurement of ASL-based perfusion and
31P spectroscopy to assess changes in blood flow and ATP and its metabolites, respectively, in
response to exercise (108). Another approach pursued the measurement of perfusion, through
MRI-based plethysmography, and of deoxymyoglobin concentration through non-localized
spectroscopy, providing a quantitative measure of microvascular and skeletal muscle tissue
oxygen saturation and hence muscle oxygen consumption (109). Several other methods have
been introduced that measure two of the previously introduced processes simultaneously.

1.4.6.1. Perfusion and BOLD
Duteil, et al described a method to measure both the perfusion and BOLD response from
the same series of images: either the subtraction of label and control images to quantify
perfusion, or the addition of these two images to assess BOLD signal changes (51). As the BOLD
response is a multi-factorial in mechanism, the authors postulated that the combined method
might help to distinguish the different contribution of perfusion increases to the change in the
BOLD contrast or of changes in oxygen saturation in the capillary bed.
Other methods have been proposed for the combined measurement of perfusion and
BOLD changes. For example, a double excitation sequence for simultaneous quantification of
ASL and BOLD was proposed by Walvick, et al (110), and later refined by Mendes, et al for the
additional measurement of T2 (111,112). In the more recent adaptation (112), the image
acquisition for perfusion quantification is followed by a separate dual-echo acquisition to quantify
T2*. The subsequent NS or SS inversion also acts to refocus the magnetization for quantification
of T2.
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1.4.6.2. Flow and SvO2
Combined measure of flow and SvO2 can be achieved using several different methods.
Langham, et al introduced a method to measure time resolved flow via projections and field maps
for SvO2 quantification using susceptometry-based oximetry, as detailed earlier (88). This method
was applied in patients and healthy controls during an ischemia-reperfusion paradigm, and
results of flow and SvO2 were analyzed independently (66).
More recently, Mathewson, et al (113) utilized a similar combined flow and SvO2 method
to investigate the off-kinetics of exercise, that is the transition between exercise and rest. Flow
and SvO2 were measured in the femoral vein following quadriceps exercise, and from these data,
muscle oxygen consumption (𝑉𝑂! ) was calculated via the Fick principle as:
𝑉𝑂! = 𝐶! 𝑂! ∙ 𝑓𝑙𝑜𝑤 ∙ 𝑆𝑎𝑂! − 𝑆𝑣𝑂!

[1.12]

where CaO2 is the arterial oxygen content. It is important to note that the calculation of
oxygen consumption cannot be so easily computed from reactive hyperemia studies since the
measured changes in SvO2 reflects the aggregate effect of the desaturation during ischemia
rather than reflecting the current capillary bed oxygen saturation.
Others have investigated an approach that quantifies muscle oxygen consumption either
by empirical calibration (49) or theoretical relationship between %HbO2 and T2’, the RF-reversible
component of the transverse relaxation time

!
!! ∗

=

!
!!

+

!
!! !

(114). Therefore, instead of bulk flow

and draining vein SvO2, perfusion and microvascular SvO2 were measured via a combined ASL
and T2’-based methods (115,116). T2’-based oximetry methods have been used to quantify
oxygen saturation on a voxel-wise basis in the brain (114), and combined with ASL-based
perfusion can quantify the rate of oxygen consumption either in the steady state of an isometric
contraction (115), or in response to the transition between exercise and rest (116).
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1.4.6.3. Bulk flow and perfusion
Another interesting combined measurement is the assessment of blood flow in the large
arteries and blood flow in the capillaries, measured for instance as the combination of phase
contrast flow and ASL perfusion. Zhang et al pursued a method to investigate these two
parameters through Doppler ultrasound to quantify bulk arterial flow in the popliteal artery, and
ASL MRI was used to determine perfusion (117). Although these investigations are still in an
early stage, this combined measurement may provide insight into the specific reactivity of the
microvasculature.

1.3. Outline of Dissertation Chapters
This dissertation describes the development and application of MRI-based methods for
the measurement of peripheral vascular function. In Chapter 2, an interleaved pulsed arterial spin
labeling and multi-echo GRE method, termed perfusion, intravascular venous oxygen saturation,
and T2* (PIVOT) is described, evaluated compared to standard non-interleaved approaches, and
applied to a small cohort of young healthy subjects and patients with peripheral artery disease. In
Chapter 3, the PASL method for perfusion quantification is compared to pseudo-continuous ASL
(pCASL) and implications of the changes in average arterial blood flow on the precision of pCASL
quantified perfusion are investigated. In Chapter 4, the original PIVOT sequence is expanded to
include an upstream velocity-encoded multi-echo GRE outside of the PASL portion of the
sequence. This expanded three-slice interleaved sequence permits quantification of perfusion,
SvO2, and T2* alongside arterial and venous bulk flow at four second temporal resolution,
providing a comprehensive tool for evaluation of peripheral vascular function. Using both postischemia reactive hyperemia and post-exercise functional hyperemia stimuli, the relationship
between blood flow in the macro- and microvasculature was investigated, and oxygen
consumption was quantified following exercise. Finally, in Chapter 5, the PIVOT method outlined
in Chapter 2 was applied in a cohort including 96 patients with varying degrees of peripheral
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artery disease and 10 healthy subjects. Results show that the reactive hyperemia timing
response is highly correlated with the clinical measure of disease severity.
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CHAPTER 2: COMBINED MEASUREMENT OF PERFUSION,
VENOUS OXYGEN SATURATION, AND SKELETAL MUSCLE T2*
DURING REACTIVE HYPEREMIA IN THE LEG
2.1. Abstract
Purpose: To develop and evaluate an MRI technique for simultaneous measurement of
perfusion, venous oxygen saturation (SvO2), and skeletal muscle T2*.
Methods: Perfusion, Intravascular Venous Oxygen saturation, and T2* (PIVOT) is comprised of
interleaved pulsed arterial spin labeling (PASL) and multi-echo gradient-recalled echo (GRE)
sequences. During the PASL post-labeling delay, images are acquired with a multi-echo GRE to
quantify SvO2 and T2* at a downstream slice location. Thus time-courses of perfusion, SvO2, and
T2* are quantified simultaneously within a single scan. The new sequence was compared to
separately measured PASL or multi-echo GRE data during reactive hyperemia in five young
healthy subjects. To explore the impairment present in peripheral artery disease patients, five
patients were evaluated with PIVOT.
Results: Comparison of PIVOT-derived data to the standard techniques shows that there was no
significant bias in any of the time-course-derived metrics. Preliminary data show that PAD
patients exhibited alterations in perfusion, SvO2, and T2* time-courses compared to young healthy
subjects.
Conclusion: Simultaneous quantification of perfusion, SvO2, and T2* is possible with PIVOT.
Kinetics of perfusion, SvO2, and T2* during reactive hyperemia may help to provide insight into
the function of the peripheral microvasculature in patients with PAD.
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2.2. Introduction
As discussed in Chapter 1, peripheral artery disease (PAD) causes significant morbidity
and mortality in the United States (11-13,118). Baseline blood flow to skeletal muscle is generally
maintained through the recruitment of collateral arteries (15,119), however the vasculature is
unable to quickly respond to changes in metabolic demand, such as those that occur with
exercise or following a period of ischemia. Analogous to cardiac stress testing, the functional
integrity of the peripheral vasculature can be interrogated by measuring the dynamic response to
a period of induced ischemia. This period of transient ischemia causes buildup of vasodilator
metabolites and reduces the vascular resistance in the capillary bed. Upon release of the
proximal arterial occlusion reactive hyperemia ensues, and the kinetics of the hyperemic
response can provide information on microvascular integrity and endothelial function. The
vasculature of healthy subjects is able to rapidly respond to the increase in flow, recovering to
baseline more quickly than patients with PAD (52,66,68).
Also as introduced previously, there are several MRI methods that can yield data that are
sensitive to the dynamic processes that occur during reactive hyperemia. Independently,
perfusion (52), SvO2 (67), and T2* (68,69) have been used to evaluate the hyperemic response.
Additionally, the measurements of perfusion and the BOLD signal have been combined to
simultaneously investigate the relative changes in microvascular flow and capillary bed oxygen
saturation (51,120). However, these methods have not been able to also investigate SvO2
kinetics. On the other hand, measurement of SvO2 has been combined with the measurement of
macrovascular flow (66,88), but not with the spatially localized measurement of perfusion.
The post-ischemia recovery dynamics are altered in each of these parameters in
situations of impaired vascular function, as in PAD (52,66-69); therefore there is potentially added
benefit to concurrent measurement. Thus, in this work, we developed a method to measure
perfusion, SvO2, and T2* simultaneously. Such a technique allows for a more complete functional
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assessment of the peripheral vasculature during a single scan providing information on the
temporal relationships between these various functional parameters.

2.3. Theory
The technical foundations of ASL perfusion quantification, MR susceptometry based
oximetry, and the measurement of BOLD signal changes have already been described Chapter 1.
To briefly summarize, perfusion can be measured through ASL by taking the difference
between images acquired with and without magnetically labeling the inflowing blood (45,76).
These images are known as the label and control images, respectively. Aside from the application
of the labeling pulse the label and control images are otherwise identical, thus the difference
between them cancels out signal contribution from the static tissue and the leftover signal can be
converted into perfusion in absolute physiologic units (34,47,80,81). Specific to this application, a
method proposed by Raynaud, et al for the measurement of perfusion in skeletal muscle uses
slice-selective and non-selective inversion pulses to achieve the label and control conditions. To
reset the magnetization, a saturation pulse follows each image acquisition. This variant of the
PASL-FAIR method is known as Saturation Inversion Recovery (SATIR) (34). Essential to all ASL
methods is the presence of a delay time between the application of the label and the image
acquisition, known as the post-labeling delay (PLD). The PLD is necessary to allow the transit of
labeled blood water into the tissue.
In MR susceptometry, venous oxygen saturation is quantified by measuring the local
magnetic field offset induced by the presence of an accumulation of paramagnetic
deoxyhemoglobin (e.g. large draining vein) (58,87). By modeling the vein as a long paramagnetic
cylinder, the field offset, measured as the difference in inter-echo phase accrual between the vein
and background tissue, can be directly related to the concentration of deoxyhemoglobin provided
that the vein is relatively parallel to the main magnetic field (59,121). Therefore a field mapping
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sequence, such as a multi-echo GRE, can be used to quantify SvO2 in physiologic units (%
HbO2).
The BOLD signal refers to the measurement of relative changes in the effective
transverse relaxation time (T2*), and is related to changes in blood oxygen level in the capillary
bed, perfusion, and cellular pH, and is also associated with vessel diameter and vessel
orientation (100-103). Quantification of T2* can be achieved by fitting signal intensity (SI) data
from a multi-echo GRE to a monoexponential function.
Thus, a multi-echo GRE sequence can be used to measure both SvO2 from the evolution
of the signal phase, and T2* from the rate of decay of the signal magnitude. Here, a sequence is
introduced, termed Perfusion, Intravascular Venous Oxygen saturation, and T2* (PIVOT). PIVOT
makes use of the PLD dead time inherent to all ASL sequences to acquire multi-echo GRE data
at a separate, downstream slice location (Figure 2.1). This allows dynamic quantification of
perfusion, SvO2, and T2* within a single scan.
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Figure 2.1. Pulse sequence diagram of PIVOT. A slice-selective (shown by SS
only gradient) or non-selective adiabatic inversion pulse labels blood for
perfusion imaging. During the PLD a keyhole multi-echo GRE acquires data
downstream from the perfusion slice location for SvO2 (blue) and T2* (green)
analysis. An EPI readout at isocenter (red) is used to acquire the images for
perfusion quantification.

In PIVOT, as in SATIR, label and control conditions for perfusion imaging are achieved
using SS and NS inversion pulses, respectively. During the PLD, a keyhole (122) multi-echo GRE
sequence acquires data at a distal slice for SvO2 and T2* quantification. The distal location was
chosen to ensure that the multi-echo GRE interleave does not impact the signal from previously
labeled perfusing blood. Because the NS inversion affects both the PASL and multi-echo GRE
slices, only multi-echo GRE data acquired following SS inversion are analyzed, though the
interleave is run every PLD to control for magnetization transfer effects. The multi-echo GRE is
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immediately followed by a GRE-EPI readout at isocenter to capture data for perfusion
quantification.

2.4. Methods
2.4.1. Study Design
The University of Pennsylvania’s Institutional Review Board approved all imaging
procedures, and each subject provided informed consent prior to his or her participation. To
evaluate PIVOT compared to the standard measurement methods, five young healthy male
subjects (27±2 years old) were recruited and imaged on two separate occasions (Visit 1 and Visit
2). Four ten-minute scans were run in both sessions, each scan consisting of one minute
baseline, three minute arterial occlusion, and six minute recovery. PIVOT, a repeat of the PIVOT
scan (PIVOT Repeat), an otherwise identical PASL-only sequence, or otherwise identical multiecho GRE-only sequence was run in a randomized order. To ensure the PASL interleave did not
impact quantification of SvO2 and T2*, dynamic SvO2 and T2* results obtained with PIVOT were
compared to the multi-echo GRE-derived SvO2 and T2* results. Similarly, to ensure the multi-echo
GRE interleave did not confound perfusion, the perfusion results obtained with PIVOT were
compared to the PASL-derived perfusion data. PIVOT was repeated to provide data on the intrasession variability of these parameters.
In addition, five PAD patients (67.2±6.8 years old, ankle-brachial index (ABI) = 0.61±0.14,
3 male) were drawn from an ongoing study and PIVOT imaging was performed during a single
ischemia-reperfusion paradigm. For experiments in PAD patients, the total scan time was 12
minutes, with 2 minutes of baseline, 5 minutes of arterial occlusion, and 6 minutes of recovery.
Since repeated arterial occlusions were not performed in PAD patients, a longer ischemic
duration was used to ensure a maximal hyperemic response.
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2.4.2. Imaging
PIVOT, PASL-only, and multi-echo GRE-only sequences were written in SequenceTree
(123) and exported for use on a 3T scanner (Siemens Medical Equipment; Erlangen, Germany).
Each subject was positioned with the maximum girth of the calf centered in an 8-channel
transmit/receive knee coil (InVivo, Inc; Gainesville, FL). For proximal arterial occlusion, a cuff was
secured around the thigh and was rapidly inflated to 75 mmHg above the systolic pressure using
the Hokanson E20 AG101 Rapid Cuff Inflation System (D. E. Hokanson, Inc; Bellevue, WA).
Perfusion images were acquired with a partial Fourier GRE-EPI readout with the following
2

parameters: FOV=250×250 mm ; acquired matrix=80×50, reconstructed to 80×80; slice
thickness=1 cm; slice location=isocenter; TR/TE=1 s/8.05 ms; PLD=952 ms. The keyhole multi2

echo GRE used the following parameters: FOV=96×96 mm ; keyhole acquired matrix=96×24, (for
SvO2 data analysis, reconstructed matrix=96×96 using a fully sampled reference image obtained
immediately after the dynamic PIVOT or multi-echo GRE acquisition; only dynamic data were
used for T2* analysis, with acquired matrix = reconstructed matrix=96×24); slice thickness=1 cm;
slice location=3 cm inferior from isocenter; TR/TE1/TE2/TE3/TE4/TE5=38.12/3.78/6.99/12.32/
19.32/26.32 ms. Perfusion, SvO2, and T2* each were quantified with two-second temporal
resolution.

2.4.3. Data Analysis
Perfusion: Perfusion was measured in the soleus muscle. High spatial-resolution scout
images were used as a reference, and a region of interest (ROI) in the soleus was visually
selected on the EPI images. As the GRE-EPI data are inherently T2*-weighted, SI variation
occurred throughout the ischemia-reperfusion paradigm due to the BOLD effect. Direct
subtraction between adjacent NS and SS images would yield data with a mixture of perfusion,
and ΔT2*-weighting. To account for this potential confound, NS time-series data were linearly

33

interpolated to temporally match the SS time-course prior to perfusion quantification (124).
Perfusion (f) was calculated as described by (34):
!

!!! ! -!!" !

!

!!! ! !!!" !

f = - ∙ ln

∙ 1-e

!

!!

+1

[2.1]

where MSS and MNS are the signal intensities (SI) in the image acquired after SS and NS
inversion, respectively, λ is the tissue partition coefficient (0.9 mL/g), T is the PLD, defined as the
time between the inversion pulse and readout, and T1 is the longitudinal relaxation time of arterial
blood. At 3T, T1blood = 1664 ms (125) and T1tissue = 1420 ms (126). A numerical calculation based
on actual values for blood and tissue T1 shows that for perfusion values up to 100 mL/min/100g,
using T1tissue ≈ T1blood = 1420 ms, underestimates perfusion by less than 5%. In order to correct for
baseline perfusion offset, the average perfusion during the period of arterial occlusion was
calculated and subtracted from each time-point as described in (124). Peak hyperemic flow
(PHF), time to peak (TTP), hyperemic flow volume (HFV), and hyperemic duration were
measured (Figure 2.2a).
Oximetry: Dynamic SvO2 images were reconstructed to a matrix size of 96×96 using
outer k-space data from a fully sampled reference image acquired immediately after the dynamic
scan (122). A phase difference image was generated for each of the dynamic time-points and the
low spatial-frequency phase modulation was removed as described in (99). An ROI was
prescribed in the larger of the peroneal veins, and reference tissue was selected in an ROI
immediately surrounding the peroneal vein. The phase accumulation was calculated from echoes
at TE1 and TE2, with DTE=3.21 ms and the difference between the intravascular and
extravascular phase accumulation ∆𝜑 was computed. SvO2 was calculated as described in (58)
as:

𝑆𝑣𝑂! = 1 −

!

∆!

∆!"
! ∆!!" ∙!"#∙!! !"#! !!! !

×100
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[2.2]

where Δχdo represents the susceptibility difference between fully oxygenated and fully
deoxygenated blood (Δχdo = 4π•0.27 ppm (SI units) (96,97)), B0 is the main magnetic field
strength, and θ is the angle of the vessel with respect to B0 (58,87). Hematocrit of 0.45 was
assumed for the healthy subjects, and the PAD patients’ hematocrit was measured by blood
draw. Washout time (time at which minimum SvO2 occurs), upslope, representing the rate of
venous resaturation (maximum slope during recovery), and overshoot (peak SvO2 – baseline
SvO2) were recorded (Figure 2.2b).
T2*: T2* analysis was performed on keyhole-only data since high spatial resolution is not
necessary (acquired matrix = reconstructed matrix = 96×24). T2* was calculated by fitting a
monoexponential function to magnitude SI from echoes TE2-TE5. Even though TE1 should have
highest SNR, TE1 was not included in the monoexponential fitting because large switching
gradients just prior to TE1 induced significant eddy current effects that would potentially confound
T2* quantification. For BOLD analysis, average SI in an ROI prescribed in the soleus muscle for
each of the four echoes was fitted to a mono-exponential function to determine T2* at each timepoint. T2* values were normalized to the baseline average and relative T2*min, relative T2*max, and
time to peak (TTPT2*) were determined (Figure 2.2c).
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Figure 2.2. Schematic of time-course for perfusion (a), SvO2 (b), and T2* (c)
illustrating the time-course-derived metrics for each parameter. Grey box
indicates the period of proximal arterial occlusion.

2.4.4. Statistical Analysis
The average and standard deviation of every time-point across all subjects and both
sessions was calculated for PIVOT, PASL, and multi-echo GRE time-course data. Pearson’s
correlation coefficient was calculated to compare the time-courses measured with PIVOT and the
standard methods.
For each key time-course-derived parameter, Wilcoxon signed-rank tests were used to
assess whether statistically significant differences exist between PIVOT and the standard
method. Specifically, PIVOT-derived perfusion parameters were compared to results obtained
with PASL-only, and PIVOT-derived SvO2 or T2* parameters were compared to results from the
multi-echo GRE. Wilcoxon signed-rank tests were also used to determine whether significant
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differences exist between key parameters measured with PIVOT and PIVOT Repeat. Wilcoxon
signed-rank tests were used in lieu of a standard paired Student’s t-test as only five subjects were
enrolled in the evaluation study and thus it cannot be assumed that the data are normally
distributed. Statistical significance was set at p<0.05.
To assess both intra-session and inter-session repeatability, the average within-subject
coefficient of variation (CV) was calculated. Specifically, to calculate intra-session repeatability,
for each parameter the within-subject standard deviation across PIVOT and PIVOT Repeat from
Visit 1 was averaged across subjects, then divided by the between-subject mean parameter value
from Visit 1. The same analysis was performed for intra-session repeatability on data acquired
during Visit 2. Similarly, to calculate inter-session repeatability, the within-subject standard
deviation across all PIVOT scans from Visit 1 and Visit 2 (4 measurements per subject) was
averaged across all subjects and divided by the between-subject mean parameter value from
both visits.
In the PAD patients, all time-course parameters described above were calculated, but no
statistical analyses were performed since patients included in this preliminary study have varying
disease severity and the ischemia-reperfusion paradigm was slightly different. The purpose of
including PAD patient data was for proof of principle and to explore differences that exist between
patients and healthy subjects.

2.5. Results
2.5.1. PIVOT evaluation in young healthy subjects
Example images are shown for a representative subject in Figure 2.3. High-resolution
images corresponding to the PASL (isocenter) and multi-echo GRE slices (30 mm inferior) along
with highlighted regions indicating the muscle or vein of interest are included in panels (a) and
(b). Sample baseline and peak hyperemia perfusion maps are shown in (c) and (d), respectively.
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These images highlight the dramatic increase in perfusion that occurs in response to induced
ischemia. The green box in (b) shows the full FOV of the multi-echo GRE. Because the FOV of
the multi-echo GRE was only 96×96 mm, aliasing along the phase-encoding direction occurred in
several subjects. In this subject, the tibialis anterior muscle has wrapped posteriorly, and part of
the gastrocnemius muscle has wrapped anteriorly. This aliasing did not affect the quantification of
SvO2, and wrapped regions were avoided when selecting the soleus ROI for T2* measurement.
Sample phase images used for SvO2 quantification at baseline and hyperemia (corresponding to
the minimum SvO2, which occurs at the washout time) are shown in (e) and (f). Keyhole
reconstruction was used for the phase images to achieve higher apparent in-plane spatial
resolution (1×1 mm), which is necessary in order to resolve the veins. However, since spatial
resolution is less critical for T2* only data acquired every TR was used for analysis. Thus each
image in (g) has in-plane resolution of 1×4 mm.

38

Figure 2.3. Example images from a representative young healthy subject. Highresolution scout images located at isocenter (a) and 3 cm inferior (b),
corresponding to the PASL and multi-echo GRE slice locations, respectively. The
soleus is indicated in red (a) and green (b), and the blue arrow points to the
peroneal vein. Perfusion images represent baseline (c) and peak hyperemic flow
(d). Phase images are shown for baseline (e) and the washout time (f). Note the
increased phase accrual in the three veins at washout time, corresponding to a
decrease in SvO2. The blue arrow identifies the peroneal vein that was used for
dynamic SvO2 analysis. Multi-echo GRE magnitude images for each of the echo
times used to quantify T2* are shown in (g).

Data for all healthy subjects were averaged to yield an average perfusion, SvO2, or T2*
time-course in order to investigate the correlation of the results between PIVOT and PASL-only or
multi-echo GRE-only methods. For each parameter, average and standard deviation of the time-
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courses across all subjects is shown in Figure 2.4. Following cessation of arterial occlusion, the
typical reactive hyperemia response is seen in each of the measured parameters. The timecourse measured with PIVOT is in good agreement with PASL-only or multi-echo GRE-onlymeasured responses. The correlation coefficient between PIVOT and PASL average perfusion
time-course is 0.99, and between PIVOT and multi-echo GRE average SvO2 and T2* timecourses are 0.98 and 0.99, respectively.

Figure 2.4. Average time-course data measured with PIVOT and standard
measurement methods. (a) Average perfusion time-course across all young
healthy subjects measured with PIVOT (red) and PASL (black). Average SvO2
(b) and T2* (c) time-courses measured with PIVOT (blue, green, respectively)
and a multi-echo GRE (black). Error bars indicate standard deviation. Grey box
indicates period of arterial occlusion.
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Average (standard deviation) of key time-course parameters from PIVOT and the
standard measurement methods are shown in Table 2.1. The Wilcoxon signed-rank tests did not
detect statistically significant differences between PIVOT and PIVOT Repeat, or between PIVOT
and the standard measurement method for any of the key time-course parameters (p > 0.05).
Table 2.2 summarizes the intra-session and inter-session repeatability measured with PIVOT.

Table 2.1. Means and standard deviations (in parentheses) of key time-course
metrics measured with PIVOT and standard measurement methods. In five
young healthy subjects, soleus perfusion, peroneal vein SvO2, and soleus T2*
were measured with PIVOT, PIVOT Repeat, and the standard method (PASL or
multi-echo GRE) on two separate occasions (Visits 1 and 2). No statistically
significant differences in any measured parameter were detected.
Visit 1

Visit 2

PIVOT
Repeat

Standard
Method

34.5 (10.2)
18.0 (3.5)
14.0 (5.0)
46.8 (13.8)

37.9 (9.0)
17.2 (2.3)
16.2 (5.6)
53.6 (10.4)

PIVOT

PIVOT
Repeat

Standard
Method

39.2 (4.1)
18.4 (5.7)
16.7 (5.4)
48.8 (14.9)

38.3 (6.0)
17.2 (4.1)
14.4 (1.9)
44.8 (10.3)

37.6 (5.6)
17.6 (5.2)
16.1 (2.3)
49.6 (14.2)

PIVOT

Perfusion (Standard Method = PASL)
PHF (mL/min/100g)
TTP (s)
HFV (mL/100g)
Hyperemic duration (s)

34.8 (7.5)
19.6 (3.6)
17.0 (5.3)
53.6 (15.7)

SvO (Standard Method = multi-echo GRE)
2

Washout time (s)
Upslope (%HbO /s)

11.6 (2.2)

10.0 (2.0)

10.4 (1.7)

12.4 (3.6)

11.2 (4.8)

10.0 (1.4)

0.83 (0.32)

1.08 (0.47)

1.21 (0.54)

1.14 (0.42)

0.91 (0.43)

1.13 (0.48)

Overshoot (%HbO )

17.6 (7.5)

17.1 (6.1)

16.8 (7.1)

18.6 (6.5)

16.5 (7.6)

18.3 (5.0)

2

2

T * (Standard Method = multi-echo GRE)
2

Baseline T * (ms)

23.4 (1.4)

22.5 (1.5)

23.1 (2.0)

22.0 (1.9)

21.7 (1.6)

22.2 (2.0)

Relative T *

0.90 (0.04)

0.93 (0.03)

0.92 (0.01)

0.92 (0.03)

0.93 (0.04)

0.94 (0.02)

Relative T *

1.09 (0.03)

1.13 (0.04)

1.16 (0.05)

1.14 (0.05)

1.15 (0.05)

1.18 (0.05)

TTP

34.0 (11.6)

29.2 (3.6)

26.8 (5.2)

28.4 (3.6)

24.8 (5.0)

28.4 (4.8)

2

2 min
2 max

T2*

(s)
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Table 2.2. Summary of intra-session and inter-session repeatability for all timecourse-derived metrics. The within-subject coefficient of variation is shown for
PIVOT versus PIVOT Repeat on Visit 1, Visit 2, and for all PIVOT data acquired
on Visits 1 versus 2.
Intra-session
Visit 1

Intra-session
Visit 2

Inter-session
Visit 1 vs. 2

6.3%
6.0%
18.8%
15.2%

5.0%
11.1%
23.4%
25.4%

12.4%
16.4%
18.9%
19.9%

Washout time (s)
Upslope (%HbO /s)

15.7%

12.0%

18.9%

26.2%

15.8%

37.3%

Overshoot (%HbO )

15.3%

18.3%

6.5%

T2 *
Baseline T * (ms)
2

3.1%

1.3%

4.6%

Relative T *

2.4%

0.9%

1.8%

Relative T *

3.0%

1.1%

3.9%

TTP

17.9%

9.6%

19.9%

Perfusion
PHF (mL/min/100g)
TTP (s)
HFV (mL/100g)
Hyperemic duration (s)
SvO2

2

2

2 min
2 max

T2*

(s)

2.5.2. PIVOT in PAD Patients
Figure 2.5 shows the reactive hyperemia time-course for perfusion, SvO2, and T2*
measured with PIVOT in a single PAD patient and a representative young healthy subject. A
summary of key time-course parameters measured in individual PAD patients is presented in
Table 2.3 along with average values for young healthy subjects. The perfusion time-course data
show that patients experienced a lower PHF, a delay in TTP, a prolonged hyperemic duration,
and a greater HFV. The SvO2 response was also delayed and blunted; PAD patients exhibited a
longer washout time, and reduced upslope and overshoot. T2* data showed characteristic
changes expected in patients with reduced endothelial function. PAD patients had higher T2*min,
even though the ischemic duration is 5 minutes instead of 3 minutes as in the healthy subjects.
Patients’ T2*max was lower and TTPT2* was delayed. These results are in agreement with previous
findings measuring perfusion (52), SvO2 (66,67), or T2* (68,69) individually in PAD patients.
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Figure 2.5. Time-courses measured with PIVOT for perfusion (a), SvO2 (b), and
T2* (c) in one representative young healthy subject and one PAD patient (PAD #5
in Table 2.3). Light colored lines represent healthy subject, and dark colored
lines represent PAD patient. Grey box indicates period of arterial occlusion. PAD
patient exhibits a blunted and delayed hyperemic response for each of the
measured parameters compared to the young healthy subject.
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Table 2.3. PIVOT results in individual PAD patients and for the average of all
young healthy subjects.

ABI

Healthy

PAD #1

PAD #2

PAD #3

PAD #4

PAD #5

N/A

0.41

0.52

0.68

0.72

0.74

37.0 (6.1)
19.0 (4.5)
16.9 (5.1)
51.2 (14.6)

26.9
110
48.2
182

22.0
72
26.5
124

31.3
90
78.7
240

29.9
52
37.7
110

37.3
32
33.8
108

Perfusion
PHF (mL/min/100g)
TTP (s)
HFV (mL/100g)
Hyperemic duration (s)
SvO

2

Washout time (s)
Upslope (%HbO /s)

12.2 (2.2)

48

50

22

36

22

1.0 (0.6)

0.24

0.18

0.45

0.69

0.45

Overshoot (%HbO )

18.1 (6.5)

16.4

17.9

13.2

16.7

12.9

Baseline T * (ms)

22.6 (1.7)

22.2

22.4

21.6

20.4

20.0

Relative T *

0.91 (0.03)

0.93

0.94

0.92

0.95

0.94

Relative T *

1.11 (0.04)

1.04

1.04

1.11

1.04

1.12

TTP

32.8 (8.8)

120

160

94

56

68

2

2

T*
2

2

2 min
2 max

T2*

(s)

2.6. Discussion
2.6.1. PIVOT Repeatability
The repeatability assessment comparing perfusion, SvO2, and T2* metrics derived from
the two successive PIVOT scans show some intra-session variability. This variability could be
physiologic in nature or could be due to noise in the time-course data. Given the low average
baseline signal standard deviation (perfusion: 1.6 mL/min/100g; SvO2: 1.5 %HbO2; T2*: 0.5%) it is
likely that intra-session variations of key measured parameters are outweighed by physiologic
variability during separate ischemia-reperfusion episodes. In all cases there were no significant
differences detected between time-course parameters measured with PIVOT and PIVOT Repeat
(p>0.05), suggesting that there was no training effect due to multiple periods of ischemia. This
finding justifies the comparison of within-session PIVOT to PASL-only or to multi-echo GRE-only
sequences, even though the data were acquired separately.
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2.6.2. PIVOT Effect on Perfusion Quantification
In comparing perfusion metrics measured with PIVOT to those measured with an
otherwise identical PASL-only sequence, it is evident that the two measurements provide similar
values of all perfusion time-course-derived metrics. Specifically, there were no significant
differences between any of the key parameters measured with PIVOT or with PASL. This
suggests that the multi-echo GRE interleave does not impact the quantification of perfusion.
Perfusion time-course metrics had expected results for longitudinal reproducibility. A CV
of approximately 20% has been reported in previous studies (47,127). Perfusion varies
physiologically with time of day (128), hydration level (129), and hormonal fluctuations (130)
among other factors (131). Care was taken to schedule Visits 1 and 2 at the same time, and all
subjects were instructed to refrain from caffeine intake and vigorous activity for 12 hours prior.
Yet even within a single scan there was variability in the hyperemic response from one ischemiareperfusion episode to another, suggesting that these physiologic factors cannot be completely
controlled. The time-course data averaged over all experiments and all healthy subjects showed
good correlation in the shape and magnitude of the reactive hyperemia response, reflected by the
high correlation coefficients. Thus not only were the key time-course-derived metrics not
significantly different, but that the overall response was highly similar.
Peak hyperemic flow measured with either PIVOT or PASL was somewhat lower than
previously reported values, where PHF was measured to be 50±13 mL/min/100g using the same
SATIR perfusion preparation, but with a RARE readout (34). PHF in the soleus in our study was
lower, reaching only 37.0±6.1 mL/min/100g. This difference in perfusion could be attributed to the
fact that Raynaud et al quantified whole-leg perfusion (34), while individual muscle perfusion was
calculated here. Additionally, care was taken to exclude vessels from the ROI, as their inclusion
would increase measured perfusion. In another study by Proctor and colleagues, perfusion was
measured in the calf of 64 men using strain gauge plethysmography (132), a technique
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considered to be a standard for limb perfusion measurement. Peak perfusion in the calf was
found to be 35.1±1.1 mL/min/100g following a period of 10 minutes of ischemia. Both this work
and that by Raynaud (34) and Proctor (132) report much lower PHF than a similar study by Wu et
al using continuous arterial spin labeling (CASL). In Wu’s study, PHF in the soleus muscle was
found to be 116±57 mL/min/100g (47), however the temporal resolution in CASL was limited to 16
seconds. Using an EPI readout, the magnitude signal over the course of an ischemia reperfusion
paradigm varies substantially due to the BOLD effect. If the time course is not sampled with high
enough temporal resolution, the changing signal intensity due to the BOLD effect may
contaminate the quantification of perfusion (84). The higher temporal resolution data acquired
with SATIR can track the changes in signal intensity better and thus may be less susceptible to
BOLD contamination, allowing more accurate quantification of perfusion.
Time to peak perfusion agreed with Raynaud’s values (34), however it was much shorter
than the TTP reported by Wu (47). Again, this discrepancy between our work and that of Wu et al
could be due to the better temporal resolution of SATIR over CASL. The temporal resolution for
PIVOT and SATIR was 2 seconds, while that of the CASL sequence employed in Wu’s work was
16 s. The improvement in temporal resolution was in part due to the pulsed labeling scheme used
in SATIR, in which arterial labeling takes only 8 ms instead of 2 seconds as in CASL.
Hyperemic flow volume quantified the total blood delivery during hyperemia, and along
with the hyperemic duration may provide more qualitative measures of hyperemia. HFV in
particular may be less sensitive to time-course noise compared to PHF and TTP. PHF and TTP
are determined based on a single data-point, whereas HFV is the total integrated area. The
values we reported for HFV and hyperemic duration were lower and shorter than those reported
by Wu, et al (47), which is not surprising since our measured PHF and TTP are lower and shorter
as well.
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2.6.2. PIVOT Effect on SvO2 Quantification
High spatial resolution is necessary to measure the phase in the vein; therefore the
keyhole multi-echo GRE data was supplemented with outer k-space data from a fully-phaseencoded reference scan that was run at the end of the dynamic acquisition. Langham et al have
previously shown that keyhole reconstruction provides accurate SvO2 results with high temporal
resolution during reactive hyperemia in the femoral vein (56).
No significant differences were detected between time-course metrics measured with
PIVOT or with the multi-echo GRE. While inter-session variability was present, it was comparable
to the intra-session variability measured between PIVOT and PIVOT Repeat on the same visit.
Average washout time was slightly lower than previously reported in the femoral vein of young
healthy subjects (17±7 s), but upslope and overshoot were in agreement with prior results (67).
The lower washout time could be explained by the fact that the tourniquet system used in this
study deflated much more quickly than that used in (67). The resulting decrease in the resistance
to arterial flow could potentially shorten the washout time. Another potential reason that washout
time differs is that we investigated SvO2 in the peroneal vein, as opposed to the more superior
femoral vein. Thus not only does the peroneal vein collect from a smaller volume of muscle, but
the distance between the capillary bed and peroneal vein was also smaller.

Overall, key

parameters measured with PIVOT agree with multi-echo GRE-derived data, suggesting that
inclusion of the PASL interleave does not impact quantification of SvO2.

2.6.3. PIVOT Effect on T2* Quantification
In both PIVOT and multi-echo GRE T2* data, the signal intensity in the ROI was first
averaged then fit to a mono-exponential function. The fitting of average signal intensity was
2

nearly perfect with an overall average R for all T2* fits of 0.999.
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During the period of arterial occlusion, relative T2* was found to decrease as the
deoxyhemoglobin concentration in the capillary bed increases. Following cuff release, hyperemic
arterial inflow replenishes blood in the capillary bed, bringing oxygenated arterial blood in and
moving desaturated blood into the large draining veins. Relative T2* increased during reactive
hyperemia due to the increase in perfusion and the decrease in deoxyhemoglobin in the capillary
bed. Even though perfusion and T2* were measured at separate slice locations, they both
represent changes that occur in the soleus muscle. TTPT2* was longer than perfusion TTP,
suggesting that the increase in oxygen concentration at the level of the capillary bed lasted longer
than the increase in microvascular flow. This finding is in agreement with a prior study
investigating the combined measurement of perfusion and BOLD during reactive hyperemia (51).
Duteil et al suggest that because the brief period of arterial occlusion does not cause significant
oxygen debt in muscle (as shown by (109)), the muscle’s demand for oxygen remains unchanged
and thus the increase in perfusion results in a decrease of oxygen extraction, causing the BOLD
signal to increase (51). The decrease in oxygen extraction also physiologically manifests as the
SvO2 overshoot.
The measured values are consistent with previous literature reported values for baseline
T2* (65), relative T2*min (69), T2*max (68,133), and TTPT2* (68). Comparisons between PIVOT and
multi-echo GRE key time-course parameters yielded no significant differences, and the T2* timecourse data measured with PIVOT and multi-echo GRE were highly correlated (Pearson’s
r=0.99). These results indicate that T2* quantification in a downstream slice with PIVOT is not
affected by the PASL interleave.

2.6.4. Considerations for Applying PIVOT in PAD Patient Studies
Statistical comparisons between PAD patients and young healthy subjects were not
made because the ischemic duration differed in the two cohorts. As repeated periods of arterial
occlusion were used to compare PIVOT to standard measurement methods in healthy subjects, a
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shortened ischemic duration was used, allowing enough time for the four scans to be performed
during one hour of scanning. PAD patients included in this preliminary evaluation had varying
disease severity, represented by the diverse ABIs. A five-minute period of arterial occlusion was
employed in PAD patients to ensure the maximal hyperemic stimulus. The PAD patient data
were, however, included to explore the range of values that exist between states of health and
disease. In agreement with the results of Wu et al, PAD patients exhibited a decrease in PHF
and an increase in TTP (52). SvO2 data showed a blunted and delayed response, in agreement
with Langham et al (66,67). T2* data showed the characteristic alterations during the period of
ischemia (69) and reactive hyperemia (68).
Quantification of multiple parameters may improve diagnosis and enhance power for
detection of the response to therapeutic intervention. The traditional marker of disease severity in
PAD is the ankle-brachial index (ABI), which is the ratio of systolic blood pressures measured at
the level of the ankle and in the brachial artery. The ABI primarily represents occlusions and
stenoses on the macrovascular level. Previous studies have shown that physiologic
improvements such as increased peak walking time do not correlate with clinically significant
changes in ABI (21,22). PIVOT provides a measure of microvascular function, thus may be more
sensitive to early treatment effects. By measuring many parameters, PIVOT will provide insight
into the relationship between impairments in perfusion, SvO2, and T2*.
In this study we showed that no major measurement bias in key time-course parameters
was introduced by using PIVOT instead of the standard individual measurement methods.
However, it should be noted that the small sample size affects the power to detect such a bias.
Even though no measurement bias was detected, the precision and thus statistical power of
PIVOT-derived measures was limited by physiologic variability, which cannot be completely
controlled. In order to use this method to assess disease presence or monitor a treatment effect,
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the study must be well designed, controlling for factors that are known to affect perfusion and the
hyperemic response (128,130,131).
The preliminary PAD patient data showed that for many of the key time-course
parameters there was a relatively wide range of values that exist between states of health and
disease. A recent study performed at 1.5T showed relatively poor repeatability of BOLD
measurements with the exception of TTPT2* during reactive hyperemia in both healthy subjects
and PAD patients (127). In our study a lower inter-session CV, and hence better repeatability,
was found for several key T2* parameters in healthy subjects. The improvement in repeatability
may be due to the higher field strength, which confers increased signal to noise ratio and greater
BOLD signal contrast. A longitudinal study will be necessary to determine the repeatability of
PIVOT measures in PAD patients. Additionally vascular reactivity decreases with age (66),
therefore it will be important to compare PIVOT results obtained for PAD patients to age-matched
healthy controls to assess the impact of age on PIVOT-derived measures of microvascular
function.

2.7. Conclusions
In summary, we have introduced a quantitative MRI method that measures perfusion,
SvO2, and T2* simultaneously, thereby allowing a comprehensive assessment of the functional
integrity of the peripheral microvasculature during a single ischemia-reperfusion paradigm. The
added value of the proposed approach will require rigorous evaluation in cohorts of patients with
impaired peripheral circulation in comparison to their healthy peers. In the future PIVOT could
possibly serve as a means to monitor disease progression and effectiveness of intervention.
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CHAPTER 3: MEASUREMENT OF SKELETAL MUSCLE
PERFUSION DYNAMICS WITH ASL: ASSESSMENT OF PCASL
LABELING EFFICIENCY IN THE PERIPHERAL VASCULATURE
AND COMPARISON OF POST-ISCHEMIA PERFUSION
MEASURED WITH PCASL AND PASL
3.1. Abstract
Purpose: To compare calf skeletal muscle perfusion measured with pulsed arterial spin labeling
(PASL) and pseudo-continuous arterial spin labeling (pCASL) methods, and to assess the
stability of pCASL labeling efficiency in the popliteal artery throughout an ischemia-reperfusion
paradigm.
Materials and Methods: At 3T field strength, pCASL labeling efficiency was experimentally
assessed in five subjects by measuring the signal intensity of blood in the popliteal artery just
distal to the labeling plane immediately following pCASL labeling or control preparation pulses, or
without any preparation pulses throughout separate ischemia-reperfusion paradigms. The relative
label and control efficiencies were determined during three distinct phases (baseline, hyperemia,
and recovery) defined based on average arterial velocity, which was measured with a projection
phase-contrast sequence. In a separate cohort of ten subjects, pCASL and PASL sequences
were used to measure reactive hyperemia perfusion dynamics.
Results: Calculated pCASL labeling and control efficiencies were unchanged throughout the
baseline, hyperemia, and recovery periods. Perfusion dynamics measured with pCASL and PASL
did not significantly differ. Average leg muscle peak perfusion was 47±20 mL/min/100g or 50±12
mL/min/100g, and time to peak perfusion was 25±3 s and 25 ±7 s from pCASL and PASL data,
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respectively. Further metrics parameterizing the perfusion time course did not significantly differ
between pCASL and PASL measurements.
Conclusion: No change in pCASL labeling efficiency was detected despite the almost ten-fold
increase in average blood flow velocity in the popliteal artery. pCASL and PASL provide precise
and consistent measurement of skeletal muscle reactive hyperemia perfusion dynamics.

3.2. Introduction
As described Chapters 1 and 2, recent studies have shown that the dynamics of
skeletal muscle perfusion can provide insight into endothelial function and vascular reactivity in
normal physiologic and pathophysiologic states (48,52,134,135). Perfusion is a tightly regulated
physiologic process, serving to provide oxygen and nutrients to active tissue, and to remove
waste products. Because metabolic demand of resting skeletal muscle is quite low, skeletal
muscle perfusion at baseline is generally maintained even in situations of disease such as
peripheral artery disease (PAD) or diabetes mellitus. However, these diseases do manifest with
an impairment of vascular reactivity.
These functional deficits of the vasculature can be evaluated by monitoring the
kinetics of the response to a situation of increased flow demand, akin to cardiac stress testing. In
skeletal muscle, this can be accomplished by measuring the response during or following
exercise (functional hyperemia) (34,107,136), or following induced ischemia (reactive hyperemia)
(34,47,51). Functional vascular impairment manifests as a blunting and delay of reperfusion in
response to the stressor (52). Even though it is not physiologically analogous to the demands of
daily living, reactive hyperemia provides a more reproducible and subject effort-independent
stimulus compared to functional hyperemia, and thus has been purported as the preferred
stressor for studying peripheral vascular function (25).
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Arterial spin labeling (ASL) permits the measurement of perfusion in physiologic units
(45,76). Previous studies have used ASL to measure perfusion in the brain (77,82), kidneys
(137), and skeletal muscle (34,47). While several ASL labeling schemes exist, they each work by
taking the pair-wise difference of two images – one with magnetically labeled blood (label) and
one without (control). Tissue magnetization is measured with and without inversion of arterial
blood water and after allowing enough time for the inverted or uninverted spins to perfuse the
organ of interest. Subtraction between the label and control images cancels out the contribution
from static tissue and yields a signal that is proportional to microvascular perfusion. This signal
can be converted into perfusion in units of mL/min/100g through application of various models
(34,47,80,81).
Skeletal muscle perfusion during hyperemia has been quantified with PASL (34),
which achieves inversion using a single adiabatic inversion pulse (77), continuous ASL (CASL)
(47) or, more recently, pCASL (48). Each of these methods has benefits and drawbacks. PASL
uses a single RF pulse for nearly instantaneous and complete inversion, therefore perfusion can
be measured at a temporal resolution of up to 2 second (34). However, pCASL and CASL utilize
a series of pulses to achieve inversion, thereby reducing labeling efficiency (82) and limiting
temporal resolution to 6-8 seconds (47,48,52). On the other hand, CASL or pCASL methods do
offer an increase in signal-to-noise ratio compared to PASL as the labeled blood water spins
accumulate in the tissue throughout the longer labeling duration (83).
Both CASL and pCASL rely on flow-driven adiabatic inversion to label arterial blood
(45,82). To achieve efficient flow-driven adiabatic inversion, blood flow velocity (v) must satisfy
the adiabatic condition:
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≪ 𝛾 𝐵!"" , where T2 is the transverse relaxation time of blood

water protons, G is the average gradient amplitude, Beff is the effective magnetic field, and γ is the
proton gyromagnetic ratio (85). Flow-driven adiabatic inversion will invert spins that satisfy this
condition. However, if blood flow velocity is too slow, transverse relaxation effects dominate, and
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blood will not be inverted. On the other hand, if flow is too fast, the effective frequency sweep rate
will be too fast the magnetization will not be inverted. Blood flow velocity, therefore must remain
in a specific range in order to achieve efficient flow-driven adiabatic inversion (138).
In contrast to the arteries supplying the brain, the peripheral circulation has higher
impedance resulting in a distinctive flow waveform (57,139,140). Specifically in the popliteal
artery, which supplies muscles in the calf, the blood flow waveform is triphasic at baseline with
antegrade flow during systole followed by retrograde then antegrade flow during diastole
(139,140). During reactive hyperemia, the flow waveform becomes entirely antegrade due to
vasodilation of capillaries to accommodate increased blood flow demand downstream (57).
Beyond the changes in the waveform characteristics, average blood flow velocity differs
substantially between baseline, ischemia, and reactive hyperemia. This variability may result in
blood flow velocity-dependent changes in labeling efficiency for techniques that rely upon flowdriven adiabatic inversion.
Theoretical explorations of the dependence of blood flow velocity on labeling efficiency
show that with decreasing peak flow, there is a decrease in labeling efficiency (76,82,138). These
simulations have been corroborated by experimental investigations of labeling efficiency
performed in the brain (141). However, those results may not apply to muscle perfusion, due to
the different characteristics of the blood flow waveform in the peripheral vasculature.
Prior studies investigating muscle perfusion dynamics with PASL and pCASL or CASL
have yielded disparate results, wherein peak perfusion measured with pCASL (48) or CASL (52)
methods was much higher than that measured by PASL (34,142). However, the precise
quantification of perfusion depends both on the acquisition approach, experimental stimulus, as
well as the analysis methods, for instance how to deal with outliers, etc., thus true comparison
between ASL methods for quantification of skeletal muscle perfusion has not yet been explored.
Current hardware limitations make implementation of CASL on clinical imaging systems difficult,
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thus the focus of this work was on comparison of perfusion quantified with pCASL and PASL.
Furthermore, to our knowledge, there has not been any exploration of the effect of the labeling
method on quantification of muscle perfusion and perfusion dynamics in a reactive hyperemia
paradigm.
The purpose of this study was to experimentally investigate pCASL label efficiency
during an ischemia reperfusion paradigm in the peripheral vasculature, and to compare muscle
perfusion dynamics measured using pCASL and PASL.

3.3. Methods
3.3.1. Experimental overview
The Institutional Review Board of the University of Pennsylvania approved all aspects
of the study. Fifteen healthy subjects were recruited to participate after providing written, informed
consent. Five healthy subjects (33±7 years old, 4 male) participated in the pCASL labeling
efficiency experiments, and ten healthy subjects (60±4 years old, 7 females) were scanned with
both PASL and pCASL sequences. All subjects were free from overt cardiovascular disease. For
each subject, all experiments were performed on the same day, within the same scan session.
Imaging was performed at 3.0 T (Siemens Magnetom Tim Trio, Siemens Medical
Equipment; Erlangen, Germany) with an eight-channel transmit/receive knee coil (InVivo, Inc;
Gainesville, FL). All experimental imaging sequences were written in SequenceTree (143).
Reactive hyperemia was induced for both sets of experiments using an ischemia-reperfusion
paradigm consisting of 3-5 minutes of proximal arterial occlusion via a pneumatic cuff secured
around the thigh. The cuff was rapidly inflated to 75 mmHg above each subject’s systolic blood
pressure using the Hokanson E20 AG101 Rapid Cuff Inflation System (D.E. Hokanson, Inc;
Bellevue, WA). Data analysis was performed with in-house-written software using MATLAB
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(MathWorks, Natick, MA), and statistical analyses were executed with JMP (SAS Institute., Cary,
NC, 1989-2007).

3.3.2. pCASL labeling efficiency during reactive hyperemia
First we aimed to assess whether pCASL labeling efficiency varies over the course of
an ischemia reperfusion paradigm. By measuring the signal intensity in the artery following
pCASL labeling period, the inversion efficiency can be experimentally estimated (144). For the
purpose of this study, precise quantification of the inversion efficiency was of less interest than its
variation over the course of the reactive hyperemia paradigm.
Relative inversion efficiency was estimated experimentally using a modified pCASL
sequence in which the imaging readout, located just distal to the labeling plane, immediately
followed the labeling or control period (Figure 3.1a). Rather than measuring signal intensity in the
muscle tissue, magnitude signal intensity was measured in the blood contained within the
popliteal artery to assess the impact of the labeling period. Following the imaging readout,
additional time was allotted for signal recovery and inflow of fresh spins in the artery.
The reactive hyperemia response is relatively short-lived, therefore temporal sampling
of popliteal artery blood signal was maximized by conducting three separate experiments: with
EPI data acquired following pCASL label; following pCASL control; or without label or control
preparations (termed M0) (Figure 3.1b). The duration of the label and control preparations were
selected to match Wu, et al’s prior study using CASL for skeletal muscle perfusion quantification
(47). For each scan, data were acquired during 1 min baseline, 3 min ischemia, and 2 min
recovery. Five subjects were scanned with this repeated reactive hyperemia paradigm (33±7
years old, 4 male). Each subject received additional time to recover back to his or her relative
baseline state between scans.
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Figure 3.1. (A) Diagram of measurement locations for both the pCASL labeling
experiments (blue slice, located 2 cm distal from labeling plane) and perfusion
quantification experiments (purple slice, located 6 cm distal from labeling plane).
For both experiments, the location of the pCASL labeling plane was
approximately at the level of the popliteal artery (grey slice). For PASL, slice
selective and non-selective inversion was used for label and control conditions,
respectively, but the perfusion measurement slice remained at the same location
as in pCASL (purple slice). (B) pCASL efficiency data were acquired from
repeated ischemia-reperfusion paradigms in which the imaging readout
immediately followed the control or label period, and were normalized by an
image in which no labeling was conducted (M0 – shown in the top line of B). A
fourth scan was conducted to measure blood flow in the popliteal artery during
the ischemia-reperfusion paradigm at the level of the labeling plane. (C) Timing
diagram for PASL and pCASL perfusion quantification sequences. C and L refer
to control (non-selective inversion) and label (slice-selective inversion)
conditions, respectively for the PASL scan. For both PASL and pCASL
measurements, the location of the imaging slice was approximately mid calf
(purple slice).

The modified pCASL sequences used the following parameters: for pCASL label or
control experiments, labeling duration = 2000 ms (in one subject, labeling duration was 1350 ms),
PLD = 1.6 ms, Hanning window-shaped pulses with average B1 = 1.7 µT, pulse interval = 1 ms,
Gmax/Gavg = 9/1 mT/m. The unbalanced control condition utilized average gradient = 0 mT/m and
180° phase shift between adjacent RF pulses. The labeling and control plane was located 20 mm
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superior from the EPI readout. The risk of unlabeled blood entering the measurement slice is
negligible as flow velocity would have to exceed 1250 cm/s to travel more than 20 mm in the 1.6
ms delay between labeling and image acquisition. The M0 experiment had identical temporal
sampling as the pCASL label and control experiments, but neither pCASL label or control module
was applied before the EPI readout. For all scans, an identical velocity-compensated GRE-EPI
2

readout was used for image acquisition with flip angle = 90°, FOV = 20×20 cm , slice thickness =
10 mm, acquired matrix = 80×50 (reconstructed to 80×80), TR/TE = 4000/8.1 ms (TR = 3000 ms
for one subject).
A fourth scan was conducted during which projection phase-contrast data were
continuously acquired in the labeling plane in order to characterize the arterial velocity waveform
throughout the ischemia-reperfusion paradigm. Although the beat-to-beat variation in arterial
velocity will not match between the scans, average arterial velocity and the velocity range
throughout the reactive hyperemia paradigms are repeatable (88). Acquisition parameters for the
projection phase-contrast scan were: FOV = 176×176 mm, slice thickness = 5 mm, acquired
matrix = 208×1, VENC = 80-120 cm/s, TR/TE = 24/6.5 ms. Fully phase encoded reference
images were acquired immediately before and after the projection data with identical imaging
parameters and acquired matrix = 208×208 to allow for quantification of velocity as described in
(57).
Briefly, to quantify velocity, a static tissue k-space projection was computed by first
masking out the artery in the reference image, then taking the inverse Fourier transform and
isolating the center k-space line (ky=0). This static tissue k-space projection was subtracted from
every dynamically acquired velocity-encoded projection to isolate blood signal (57). Then the
phase difference between adjacent positive and negative velocity-encoded projections was
computed and the average velocity across the popliteal artery was quantified with 24 ms temporal
resolution. The time-resolved velocity and maximum velocity were recorded. Projection velocity
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data were averaged over one cardiac cycle, and downsampled to match the temporal resolution
of the pCASL labeling scans.
Knowledge of average arterial velocity data served two purposes. First, the data were
used to estimate the transit time between the labeling location and the imaging slice, which will
differ between the baseline and hyperemic states. Assuming inversion at the location of the
labeling plane, the pCASL label data were then corrected for T1 recovery that occurs during the
transit time. Second, the arterial velocity data were used to divide all reactive hyperemia scans
into four periods: baseline, ischemia, hyperemia, and recovery. The hyperemic duration from the
projection velocity acquisition was used to define the hyperemia period for pCASL data as the
period of time during which the average arterial velocity was more than twice the baseline
velocity. Control efficiency was defined as

!! !!"#$%"&
!!!

where M0 is the blood signal intensity in the

M0 acquisition (without pCASL labeling), and similarly, Control is that in the pCASL control scan.
Label efficiency is defined as

!! !!"#$%
!!!

, where Label is the blood signal intensity in the pCASL

label acquisition. However, because magnitude images were used for analysis, the
experimentally measured label efficiency was defined as

!! !!"#$%
!!!

. Wilcoxon signed rank tests

were used to test whether the average label or control efficiencies differed between baseline,
hyperemia, and recovery.

3.3.3. Perfusion quantification with pCASL and PASL
Next we aimed to compare perfusion dynamics measured during an ischemia-reperfusion
paradigm with PASL and pCASL to assess whether significant differences existed between
results obtained with the two methods. Perfusion was measured with pCASL and PASL
sequences in ten healthy subjects (60±4 years old, 7 females). The reactive hyperemia perfusion
data quantified with PASL had been published previously (134). Each subject underwent three
ischemia-reperfusion paradigms consisting of 1 minute of baseline, 5 minutes of ischemia
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induced via proximal arterial occlusion, and 6 minutes of post-ischemia recovery during a 1-hour
scan session. In the first two ischemia-reperfusion scans, perfusion was quantified using a PASL
variant and in the third scan, a pCASL sequence was used to measure perfusion (Figure 3.1c).
A standard pCASL sequence as described by Alsop, et al (81) was implemented with the
following

parameters:

Single-slice

GRE-EPI:

acquisition

matrix=80×50

(partial

Fourier,

2

reconstructed to 80×80), FOV=25×25 cm , slice thickness=10 mm, TR/TE = 4000/8.1 ms.
Labeling duration and post labeling delay matched values used in Wu, et al’s prior CASL muscle
perfusion investigation (52), with labeling duration = 2 s, post-labeling delay (PLD) = 1.9 s,
Hanning window-shaped pulses with average B1 =1.7 µT, pulse interval = 1 ms, Gmax/Gavg = 9/1
mT/m. Unbalanced control condition utilized average gradient = 0 mT/m and 180° phase shift
between adjacent RF pulses. The labeling plane was located 60 mm superior to the imaging
slice. Perfusion was quantified with temporal resolution of 8 seconds.
PASL data were acquired with the Perfusion, Intravascular Venous Oxygen saturation,
and T2* (PIVOT) sequence (142), an interleaved dual-slice PASL and multi-echo GRE sequence.
PIVOT employs the saturation inversion recovery PASL variant described by Raynaud, et al (34)
for perfusion quantification. Notably, evaluation of PIVOT compared to PASL showed that no
error was introduced by interleaving the acquisition of multi-echo GRE data during the PLD, thus
quantification of perfusion is unbiased by the use of PIVOT (instead of a standard PASL
sequence). Sequence parameters were as follows: Slice-selective or non-selective adiabatic
inversion for label and control condition, respectively; single-slice GRE-EPI with acquisition
matrix=80×50 (partial Fourier, reconstructed to 80×80) identical to the pCASL imaging readout;
FOV = 25×25 cm; slice thickness = 10 mm; TR/TE = 1000/8.1ms. Labeling duration = 8 ms
(adiabatic inversion via hyperbolic secant pulse), PLD = 0.94 s. Temporal resolution of perfusion
quantified with PASL was 2 seconds.
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For both PASL and pCASL datasets, rigid-body motion correction was applied to the
time-series of label and control images using National Institutes of Health ImageJ software
(developed by Wayne Rasbands; National Institutes of Health, Bethesda, MD).

Regions of

interest (ROIs) were manually drawn on the EPI images using high-resolution anatomical images
as a reference for muscle boundaries (Figure 3.2a). After masking out the large arteries, signal
intensity was averaged in the gastrocnemius muscle, soleus muscle, peroneus muscle, and
anterior compartment, composed of the tibialis anterior and extensor digitorum longus muscles
for label and control time series data. These individual muscle ROIs were also combined to
determine the average muscle perfusion across the entire cross-section of the calf, referred to as
“whole-leg”. The EPI readout used for both PASL and pCASL sequences is T2*-weighted
resulting in appreciable change in the signal intensity of the images throughout the ischemiareperfusion paradigm, thus without any correction for the temporal offset, subtraction between
adjacent label and control images yields a difference that is unrelated to perfusion. To account for
the temporal offset between the control and label image series, adjacent control data were
averaged to yield a temporally matched control series (124). Perfusion was computed from pairs
of label and temporally-matched control data according to the appropriate models (Chapter 1,
equations 1.6 and 1.7) for each ASL method as described Chapter 1 with PLD = 1.9 s in pCASL,
0.94 s in PASL, T1,blood ≈ T1,tissue = 1420 ms (126). In the pCASL perfusion model, α is the labeling
efficiency (85%) (82), τ is the labeling duration (τ = 2000 ms).
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Figure 3.2. High-resolution anatomical images were used to define muscle
boundaries for region of interest selection (A). Perfusion time courses were
generated for each muscle ROI (B). Grey box indicates period of ischemia.
Reactive hyperemia ensues following deflation of the cuff. Metrics of the dynamic
reactive hyperemia response including the peak perfusion, time to peak perfusion
(TTP), hyperemic flow volume (HFV), and the hyperemic duration were
calculated.

Cuff inflation and deflation resulted in slight motion of the calf, thus the pair of label and
control images acquired immediately after inflation or deflation were excluded from the time
series. The baseline perfusion offset was calculated by averaging perfusion during the period of
cuff ischemia (47), and the offset was then subtracted from each time point. PASL and pCASL
perfusion time courses were smoothed to minimize non-physiologic noise using a three-time point
sliding-window average. The peak perfusion, time to peak perfusion, hyperemic flow volume, and
the hyperemic duration were identified and recorded from the perfusion time courses for each
muscle ROI (Figure 3.2b). Wilcoxon signed rank tests were performed for repeated measures of
perfusion. Holm adjustment for multiple comparisons was applied to all tests to maintain the
family-wise error rate of 0.05. Thus, for all tests, Pholms<0.05 was considered to be significant.
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3.4. Results
3.4.1. pCASL labeling efficiency during reactive hyperemia
Figure 3.3a shows the temporally resolved and average velocity in a single
representative subject throughout the ischemia reperfusion paradigm as measured in the
popliteal artery at the location of the pCASL labeling plane. Velocity during the baseline period
(Figure 3.3b) exhibited the expected triphasic waveform, with antegrade flow during systole,
followed by slight retrograde and antegrade flow during diastole. During the hyperemic period
blood flow became monophasic, as it was antegrade during both systole and diastole (Figure
3.3c). From baseline to peak hyperemia, the average blood velocity increased by approximately
tenfold and the peak velocity during systole roughly doubled. Across all subjects, the average
baseline blood flow was 3.9±0.9 cm/s, and the diastolic to systolic range was -13.7±2.1 to
46.3±5.4cm/s. The average peak hyperemic blood flow was 34.1±12.5 cm/s, with a range of
14.0±6.4 to 87.6 ±33.6 cm/s.
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Figure 3.3. (A) Temporally resolved (light red) and averaged over 1 second (dark
red) blood flow velocity in the popliteal artery in a representative subject. The first
20 seconds of data acquisition were used to acquire the reference image used to
generate a tissue k-space projection. Baseline VENC was 80 cm/s and was
raised to 120 cm/s at approximately 170 s into the experiment to account for the
higher flow velocities during hyperemia. (B) Temporally resolved velocity from
the baseline period in (A) shows the typical and expected triphasic waveform. (C)
During reactive hyperemia, the blood flow is entirely antegrade, with forward flow
throughout the cardiac cycle.
The variability in blood flow velocity throughout the baseline and reactive hyperemia
segments was not found to significantly impact labeling efficiency. Figure 3.4 shows the average
label efficiency with and without correction for the T1 recovery during the transit time between the
labeling plane and image slice location and the control efficiency, as well as the average blood
flow velocity during the ischemia reperfusion paradigm. T1-corrected label efficiency data were
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not calculated during the period of ischemia (grey box) since there is no flow, but through the
uncorrected label data, we observe that the label and control conditions had similar signal
intensity with respect to M0. During baseline, hyperemia, and recovery, a significant change in
control or T1 recovery-corrected label efficiencies was not detected (Table 3.1).

Figure 3.4. Control and label efficiency are plotted over the course of the
ischemia reperfusion paradigm (grey box indicates period of arterial occlusion).
Label efficiency data are plotted both with (black) and without (grey) correction
for T1 recovery during the transit time between the labeling plane and the imaging
slice location. The transit time was calculated as the separation distance (20 mm)
divided by the average velocity (shown in red). Data are averaged across all
subjects and error bars indicate standard error. Blood velocity was used to define
the hyperemic period (indicated by the red box) as the time during which average
blood velocity was at least more than double the average baseline velocity. No
significant differences were detected between the baseline, hyperemia, and
recovery periods for control or label efficiency.
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Table 3.1. Average (standard deviation) of control and label efficiencies during
the average baseline, hyperemia, and recovery periods.
Baseline

Hyperemia

Recovery

Control efficiency (%)

88 (5)

89 (5)

89 (4)

Label efficiency (%)

77 (9)

75 (7)

81 (10)

3.4.2. pCASL versus PASL
One subject was excluded from the analyses because the cuff-occlusion paradigm did
not result in a reactive hyperemia response in pCASL data. Averaged over the remaining nine
subjects, significant differences between the temporal dynamics of perfusion measured with
PASL and pCASL were not detected in any muscle groups. Table 3.2 shows the results of the
parameterized time-course data. Significant differences were not observed between PASL and
pCASL or between the two PASL acquisitions for any of the perfusion time course metrics.
Perfusion time courses were calculated for each scan and were averaged across all subjects
(Figure 3.5). Similar to the results in Table 3.2, the measured whole-leg perfusion dynamics
appear to be in agreement between pCASL and PASL despite the differences in labeling method,
post-labeling delay, and perfusion quantification model.
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Figure 3.5. Perfusion time course averaged across 9 subjects quantified with
pCASL (purple), and two identical PASL scans (grey and black). Grey box
indicates period of arterial occlusion. Error bars indicate standard error. The
reactive hyperemia perfusion time course did not significantly differ between
PASL and pCASL measurements.
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Table 3.2. Average perfusion time course metrics measured with pCASL or
PASL. Two identical PASL scans were conducted to assess repeatability of the
measured hyperemic response. Results shown are average (standard deviation).
pCASL

PASL (scan 1)

PASL (scan 2)

Gastroc Peak Perfusion
(mL/min/100g)

41 (9)

51 (11)

52 (13)

Soleus Peak Perfusion
(mL/min/100g)

50 (26)

78 (33)

69 (28)

Peroneus Peak Perfusion
(mL/min/100g)

50 (6)

41 (12)

45 (12)

AC Peak Perfusion
(mL/min/100g)

47 (13)

44 (16)

45 (14)

Whole-Leg Peak Perfusion
(mL/min/100g)

47 (20)

51 (12)

50 (12)

Gastroc TTP Perfusion (s)

23 (3)

33 (9)

30 (8)

Soleus TTP Perfusion (s)

28(8)

30 (12)

22 (7)

Peroneus TTP Perfusion (s)

26 (5)

27 (10)

24 (7)

AC TTP Perfusion (s)

23 (3)

20 (8)

18 (7)

Leg TTP Perfusion (s)

25 (3)

27 (7)

23 (7)

Gastroc HFV (mL/100g)

33 (10)

42 (13)

37 (14)

Soleus HFV (mL/100g)

39 (23)

70 (35)

52 (24)

Peroneus HFV (mL/100g)

29 (10)

23 (8)

20 (7)

AC HFV (mL/100g)

25 (11)

22 (10)

18 (5)

Leg HFV (mL/100g)

33 (15)

42 (12)

38 (13)

Gastroc HD (s)

82 (21)

88 (14)

90 (21)

Soleus HD (s)

80 (29)

101 (35)

102 (28)

Peroneus HD (s)

73 (22)

68 (17)

65 (26)

AC HD (s)

65 (45)

71 (25)

63 (20)

Whole-Leg HD (s)

77 (19)

99 (22)

105 (29)

Gastroc signifies the gastrocnemius muscle, AC the anterior compartment, TTP the time to peak,
HFV the hyperemic flow volume, and HD the hyperemic duration.
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3.5. Discussion
3.5.1. pCASL labeling efficiency
Previous studies have investigated the impact of temporal variation of blood velocity
on the measured perfusion in the brain (138,141,145,146). In the brain, all blood delivered
through the internal carotid and vertebral arteries traverses the brain via capillary microcirculation.
A simple method to experimentally measure pCASL labeling efficiency was reported by Aslan, et
al (141) in which total cerebral blood flow was measured in both the internal carotid and vertebral
arteries using phase contrast MRI and was compared to whole-brain averaged blood flow
measured by pCASL. If all other assumptions in the perfusion model are correct, the difference
between total cerebral blood flow measured by phase contrast and pCASL can be accounted for
by the labeling efficiency.
The approach utilized by Aslan, et al cannot be employed in the peripheral circulation
for several reasons. First, blood flow in the popliteal artery is not exclusively delivered to the calf
muscles. The popliteal artery branches to supply muscles of the foot, and also delivers blood to
the skin, intra-muscular fibrous tissue, bone, and other structures, thus a precise and specific
measure of muscle blood flow in a large artery is difficult. Furthermore, even if a distinct measure
of total muscle blood flow in the feeding artery were achieved, the PASL and pCASL sequences
employed in this study provided single-slice measurements therefore do not yield total muscle
blood flow.
The methodology employed herein was not directed to measure absolute labeling
efficiency, although a similar approach has been used to measure labeling efficiency in a
phantom experiment (144). The more pertinent question was to determine whether the labeling or
control efficiency was impacted by the substantial changes in average arterial velocity between
rest and reactive hyperemia in skeletal muscle. As expected, the control condition did not
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significantly impact signal in the feeding artery, and control efficiency remained relatively constant
throughout the paradigm. No significant change was detected in labeling efficiency during the
period of hyperemia compared to the baseline and recovery periods.
The correction of the label signal intensity for T1 recovery is a necessary step as the
transit time between the labeling location and the imaging slice location differs substantially
between the baseline and hyperemic states. For example, at an average blood flow velocity of
approximately 4 cm/s at baseline it would take 0.5 seconds for the blood to traverse the 20 mm
separation between the labeling plane and image slice location. If the blood water spins were
100% inverted at the labeling plane, this would account for ~ 26% signal recovery. However,
during hyperemia, arterial velocity increases by an order of magnitude, and the blood would
traverse the distance between the labeling and imaging locations in only 0.05 seconds, resulting
in much less time for T1 recovery (only about 3% signal recovery). Following correction for this
effect, there is no significant difference between the calculated label efficiency during the
baseline, hyperemia, and recovery states.
Experimentally derived average labeling efficiency of approximately 75% was lower
than the estimated 85% labeling efficiency achieved in the brain (82), or the 94% labeling
efficiency used in a previous muscle pCASL study (48). Partial-volume effects due to the low
resolution of the EPI readout may have caused underestimation of the calculated labeling
efficiency, however this would likely not affect the observed relative constancy of labeling
efficiency between baseline and hyperemia.
The finding of relative stability of labeling efficiency is surprising, as studies in the
brain have shown a significant decrease in labeling efficiency in response to a stimulus that
increases arterial velocity (141). Potentially, the periods of retrograde and low velocity antegrade
blood flow during diastole at baseline may not substantially contribute to the downstream delivery
of blood, and therefore may not impact the overall labeling efficiency. Rather than blood water
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spins traveling forward at a constant velocity of 5 cm/s, blood in the artery spurts forward at
speeds approaching 40 cm/s, but only for the short systolic period. This hypothesis is supported
by 4D flow measurements of blood flow in the peripheral vasculature (74), which show fast
forward flow during systole, and near stagnation during diastole.

3.5.2. Perfusion quantification with pCASL and PASL
A subset of the data included in this study has been published previously. Specifically,
the repeated PASL measurements were used to investigate intra-session repeatability of
perfusion dynamics and to compare perfusion dynamics between healthy individuals and patients
with peripheral artery disease in (134). In the present work, we sought to examine the agreement
between skeletal muscle perfusion dynamics measured with PASL and pCASL. One subject was
excluded from the present analysis since no hyperemic response was detected with pCASL.
In the nine subjects in whom perfusion was measured with PASL and pCASL, the
quantified perfusion time course metrics were not significantly different for any muscle group. The
average perfusion time course was very similar in appearance between the two PASL scans,
implying that there was little difference between the successive reactive hyperemia responses,
and between either PASL and pCASL scans, suggesting that the different methods for measuring
perfusion may not impact the measurement precision.
Despite the differences between the employed PASL and pCASL methods in labeling
method, labeling duration, post-labeling delay, and perfusion quantification model, the quantified
time course metrics were not found to significantly differ between the two sequences for any
muscle group. Quantified reactive hyperemia peak perfusion was in approximate agreement with
prior studies using the SATIR PASL variant (34,51,142). However compared to Wu, et al’s results
from a CASL sequence (52), Grozinger et al’s results using pCASL (48), or Lopez, et al’s results
using Q2TIPS PASL (25) peak perfusion in all muscles was lower in the present study. This bias
could be attributed to different post-processing methods as we excluded macro-vessels in the
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ROI, which would increase apparent perfusion if included. It is important to note that exactly the
same muscle ROIs were used for quantification of perfusion in this study.
The present study is the first that we are aware of to directly compare skeletal muscle
perfusion dynamics with PASL and pCASL sequences. It is not without limitation, though. The
perfusion model used for PASL assumes that T1 of blood and muscle tissue are equal. This is not
the case at 3T, however, the difference between T1 of muscle and blood would result in an
approximate 5 mL/min/100g perfusion offset within the physiologic range of perfusion expected
(142).
This study did not investigate the potential impact of the difference in arterial transit
time that would occur between baseline and hyperemia. If blood flow velocity in the popliteal
artery is only approximately 4-5 cm/s at baseline, and the pCASL labeling plane is 6 cm proximal
to the imaging slice, it would take 1.2-1.5 seconds to travel in the large arteries to the imaging
slice. Additional time would be required for the blood to perfuse through the muscle tissue, thus a
longer post-labeling delay could have resulted in higher baseline perfusion. However, during
hyperemia the average flow velocity peaks around 40 cm/s, corresponding to a transit time of
0.15 s. These effects may have masked a true reduction in labeling efficiency between baseline
and hyperemia. A follow-up study investigating the effect of arterial transit time would provide
insight on this issue. Differences in arterial transit time may be more of an issue in patients with
peripheral artery disease, in which a stenosis or occlusion may be present distal to the labeling
plane, proximal to the perfusion imaging slice. This would result in an apparent perfusion
reduction, but would be due to the increase in arterial transit time due to impaired arterial flow.
The impact of arterial transit time is less of an issue for PASL since a flow-alternating
inversion recovery variant is used. Blood only needs to travel a short distance from just outside of
the imaging slice to contribute to the measured perfusion. However, for fast flow (greater than 20
cm/s in the microcirculation), there is potential that blood from outside of the coil sensitivity profile
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could reduce the effective PASL labeling efficiency, which is assumed to be 100%. Although
blood flow velocity in the artery exceeds 20 cm/s during hyperemia, the speed of blood flow in the
arterioles and capillaries is much slower. However, this should be taken into consideration when
selecting the transmit and receive coil setup.

3.6. Conclusions
The pCASL labeling efficiency was not significantly impacted by the variation between
baseline and reactive hyperemia arterial velocity. Time course metrics were similar for both PASL
scans, and between either of PASL scans and the pCASL acquisition. The benefit of increased
temporal resolution with PASL, particularly during non-linear changes in the T2*-based EPI time
course may outweigh the theoretical benefit of the greater SNR achievable with pCASL. Overall,
reactive hyperemia perfusion dynamics were in agreement whether measured with PASL or
pCASL sequences.
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CHAPTER 4: SIMULTANEOUS QUANTIFICATION OF
MACROVASCULAR AND MICROVASCULAR BLOOD FLOW AND
OXYGEN SATURATION USING VPIVOT
4.1. Abstract
Background: The regulation of blood flow and oxygen consumption in skeletal muscle is a
dynamic, tightly controlled process. The purpose of this work is to develop and evaluate a
magnetic resonance technique for simultaneous measurement of bulk blood flow, perfusion,
draining vein SvO2, and skeletal muscle T2*.
Methods: An expanded version of the PIVOT is introduced, termed Velocity and PIVOT
(vPIVOT). vPIVOT comprises a three-slice interleaved structure for the measurement of blood
velocity and SvO2 from the superior slice, perfusion from the central slice, and SvO2 and T2* from
the inferior slice. In five subjects, vPIVOT was compared to PIVOT and a velocity-encoded dualecho GRE, termed OxFlow, during separate ischemia-reperfusion paradigms to assess the ability
of vPIVOT to accurately measure the reactive hyperemia response. Then in ten subjects, vPIVOT
was applied to assess muscle blood flow and oxygen consumption during the transition to rest
following dynamic exercise of the calf.
Results: No significant differences between vPIVOT-derived data and comparison sequences
were observed. Blood flow in the large vessels and in the capillary bed was found to respond
quickly to the cessation of induced ischemia, reaching its peak at 6±2 s, and 20±6 s, respectively.
Following exercise, macrovascular flow response was similar, reaching its maximum 8±3 s after
relaxation, however microvascular perfusion in the gastrocnemius muscle continued to rise for
101±53 s. Oxygen consumption was calculated based on either mass-normalized arterial blood
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flow, or perfusion measurements, and the peak was measured as 15.2±6.7 mL O2/min/100g or
6.0±1.9 mL O2/min/100g, respectively.
Conclusion: Simultaneous quantification of bulk blood flow, perfusion, SvO2, and T2* is possible
with vPIVOT. Together, the measurement of SvO2 and blood flow, either perfusion or bulk flow,
may be used to quantify the muscle oxygen consumption following exercise.

4.2. Introduction
As described in Chapter 1, peripheral vascular reactivity and the dynamics of muscle
metabolism may be better understood by measuring the temporal relationship of blood flow and
oxygen saturation in the micro- and macrovasculature. Indeed, through reactive hyperemia
studies, it has been shown that patients with peripheral artery disease (PAD) exhibit alterations in
recovery dynamics of perfusion (52,134), arterial blood flow (66), venous oxygen saturation
(SvO2) (66,134), and skeletal muscle T2* (68,69). Furthermore, together the measurement of
blood flow and venous oxygen saturation can provide the metabolic rate of oxygen consumption
(𝑉𝑂! ) through the Fick principle:
𝑉𝑂! = 𝐶! 𝑂! ∙ 𝑓𝑙𝑜𝑤 ∙ 𝑆𝑎𝑂! − 𝑆𝑣𝑂!

[4.1]

where CaO2 is the oxygen carrying capacity of blood (𝐶! 𝑂! = 𝐶! ∙ Hgb, Ca = 1.34 mL O2/g
hemoglobin (Hgb)), flow is either muscle-mass normalized bulk arterial/venous flow or local tissue
perfusion, and

SaO2 and SvO2 represent the arterial and venous oxygen saturations,

respectively. The measurement of time resolved skeletal muscle 𝑉𝑂! in humans remains a
difficult problem.
Recently, MRI methods to investigate the regulation of skeletal muscle blood flow and
oxygen consumption during exercise have been developed. Implementations have focused on
either the response to a sustained isometric contraction, or to the dynamics of the transition
between exercise and rest, known as the off-kinetics. Specifically, Mathewson, et al proposed a
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method to simultaneously measure venous bulk flow and intravascular venous oxygen saturation
through a projection phase-contrast and susceptometry-based oximetry approach (113). Resisted
knee extension exercise was performed, and the oxygen consumption during the off-kinetics in
the quadriceps muscles was dynamically assessed. However, the blood flow dynamics in the
large arteries and draining veins may differ from the blood flow delivery to the muscle fibers via
the capillary circulation.
An alternate approach measures blood flow and oxygen saturation locally at the level of
the capillary bed rather than in the large vessels. Blood flow is measured through ASL-MRI
(45,76) and blood oxygenation is quantified based on either empirically derived (49) or theoretical
(114) relationships between the RF-reversible transverse relaxation rate (R2’) and %HbO2. Initially
investigated by Zheng and colleagues, the image acquisition suffered from low temporal
resolution, thus limiting the acquisition to one measurement at baseline and one during a
sustained isometric contraction (115). A more recent method proposed by Buck, et al uses a
faster image acquisition strategy for the measurement of R2’, providing temporal resolution of
approximately 2.5 seconds. To calculate 𝑉𝑂! this was combined with a separate measurement of
blood flow through ASL with 4-second temporal resolution (116). Thus, the investigators were
able to assess the dynamic changes in oxygen consumption kinetics in the transition period
between rest and exercise (on-kinetics), and between exercise and rest (off-kinetics).
However, both of the R2’/ASL methods described in the previous paragraph required
separate contractions for the blood flow or oxygenation measurements. Given the presence of
variability in the physiologic response, the true temporal relationship may be slightly different
between the two acquisitions. Therefore, a combined and simultaneous method would be
desirable. While the work conducted by Mathewson, et al did allow for simultaneous
measurement of blood flow and oxygenation the measurement was not spatially localized, and
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flow may have increased in other muscles that were not specifically targeted by the exercise
paradigm.
Described in chapter 2, an interleaved pulsed ASL (PASL) and multi-echo gradient
recalled echo (GRE) sequence, termed Perfusion, Intravascular Venous Oxygen saturation, and
T2* (PIVOT) was introduced that allows for the simultaneous acquisition of perfusion, draining
vein SvO2, and the skeletal muscle BOLD response. However, presently no single technique is
capable of also measuring arterial blood flow. Concurrent acquisition of micro- and macrovascular
blood flow alongside SvO2 and T2* would offer a comprehensive functional assessment of the
peripheral vasculature and would perhaps allow investigation of the independent contributions of
macrovascular and microvascular reactivity. Furthermore, results from such an approach could
be used in aggregate to calculate muscle oxygen consumption.
To address this unmet need, the development of a 3-slice interleaved PASL and velocityencoded multi-echo GRE sequence is presented, termed Velocity and PIVOT (vPIVOT). We
hypothesize that vPIVOT allows faithful and unbiased measurement of each of the individual
parameters, and that through investigation of the off-kinetics of exercise vPIVOT will be able to
quantify 𝑉𝑂! based either on mass-normalized flow or local tissue perfusion. Furthermore, we
hypothesize that these results may allow us to address the disparity in results from prior studies.
Thus, the purpose of the work described in this Chapter was to develop a technique to
dynamically and simultaneously measure flow in the micro and macrovasculature, as well as
oxygen saturation, and to apply the technique to measurement of the off-kinetics of exercise in
human skeletal muscle.
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4.3. Methods
4.3.1. Sequence overview
Simultaneous measurement of perfusion, macrovascular blood flow, SvO2, and T2* was
achieved with a 3-slice interleaved sequence termed vPIVOT shown in Figure 4.1. As described
in Chapter 2, the original PIVOT sequence comprises a dual-slice acquisition scheme in which a
multi-echo GRE sequence acquires data at a downstream slice location from the perfusion slice
during the PASL post-labeling delay (PLD) (142). Here, the framework of PIVOT was expanded
to include an upstream velocity-encoded dual-echo GRE acquisition following the PASL EPI
readout. From the upstream dual-echo GRE data, bulk blood flow in the arteries and veins is
quantified through phase contrast, and similarly to the downstream slice, SvO2 in the vein is
quantified via susceptometry-based oximetry. Like in PIVOT, the non-selective (NS) inversion
used for the control condition of PASL will impact all tissue within the volume of the coil
sensitivity, therefore only GRE data acquired following slice-selective (SS) PASL inversion (i.e.
the label condition) are used for analysis.

78

Figure 4.1. vPIVOT pulse sequence diagram. Similar to PIVOT, multi-echo GRE
data are acquired downstream from the PASL slice location during the PLD. In
vPIVOT, velocity-encoded GRE data are also acquired after perfusion EPI
acquisition at a location superior to the PASL slice location. Perfusion is
quantified through ASL (data used are shown in light red), SvO2 through
susceptometry-based oximetry (data used are shown in blue), blood velocity
through phase contrast (data used are shown in dark red), and T2* by fitting the
magnitude signal to a mono-exponential function (data used are shown in green).
Temporal resolution for all quantified parameters is 4 seconds.

To maintain high temporal resolution sampling, keyhole reconstruction (122) was used for
both the superior and inferior GRE datasets, allowing reconstruction of high-resolution velocity
images and field maps from the dynamically acquired data. Thus only the central quarter of kspace is acquired at each time point, and fully phase-encoded reference images with otherwise
identical sequence parameters are acquired separately. The outer k-space data from the
reference images are then used to fill in k-space of the dynamic data. Keyhole reconstruction
requires that the reference images and dynamic data have exact anatomical correspondence
(e.g. no movement between the two acquisitions).

Due to the extreme motion of dynamic

exercise, data cannot be reconstructed during the exercise portion, and since there may be a
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difference in the physical location of the leg before and after exercise, the reference images are
acquired both before and after the dynamic acquisition and used for reconstruction appropriately.
The combination of MR susceptometry and phase contrast was previously proposed for
the measurement of oxidative metabolism in the brain (147,148) and was termed OxFlow. This
velocity-encoded dual-echo acquisition provides flow through the phase difference between kspace data from the first echo acquired in adjacent TRs with alternating gradient first moments.
The velocity-encoding gradients cause a constant phase offset between the first and second
echoes, therefore taking the inter-echo difference in phase accrual removes the velocity-encoded
phase. As each k-space line is encoded twice for phase contrast, those data are averaged to
reduce the noise in the field map used for SvO2 quantification.

4.3.2. Experimental protocol
vPIVOT-derived time course parameters were compared to independently acquired
PIVOT or OxFlow data throughout ischemia-reperfusion paradigms in 5 subjects. These data
allowed for the investigation of the presence of significant differences between vPIVOT and
standard non-interleaved methods. Additionally, the functional hyperemia response following a
bout of plantar flexion contractions was assessed with vPIVOT in ten healthy subjects. The
dynamics of the macro- and microvascular flow responses were compared, and gastrocnemius
𝑉𝑂! was calculated.
The Institutional Review Board of the University of Pennsylvania approved all aspects of
the study. A total of ten healthy subjects were recruited to participate after providing written,
informed consent. All imaging was performed at 3.0 T (Siemens Magnetom Tim Trio (VB17),
Siemens Medical Equipment; Erlangen, Germany) with an eight channel transmit/receive knee
coil (InVivo, Inc; Gainesville, FL). Subjects were positioned supine and the maximum crosssection of the calf was centered in the knee coil. vPIVOT, PIVOT, and OxFlow experimental
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imaging sequences were written in SequenceTree (143). Data analysis was performed with inhouse-written software using MATLAB, Version 7.12.0 (MathWorks, Natick, MA), and statistical
analyses were executed with JMP, Version 11 (SAS Institute., Cary, NC, 1989-2007). In
applicable experiments, arterial occlusion was achieved by application of supersystolic pressure
(at least 200 mmHg) via a cuff secured around the thigh inflated by a pneumatic tourniquet
system (D.E. Hokanson, Inc; Bellevue, WA). Exercise was performed against a custom-built, MRI
compatible plantar flexion ergometer.
Sequence parameters. PASL images were acquired with a partial Fourier GRE-EPI
2

readout with the following parameters: FOV = 250 × 250 mm ; acquired matrix = 80×50,
reconstructed to 80 × 80; slice thickness = 1 cm; slice location = isocenter; TR/TE = 2 s/8.05 ms;
2

PLD = 952 ms. The inferior multi-echo GRE had the following parameters: FOV = 96 × 96 mm ;
keyhole acquired matrix = 96 × 24, (for SvO2 data analysis, reconstructed matrix = 96 × 96 using
a fully sampled reference image; only dynamic data were used for T2* analysis); slice thickness =
1 cm; slice location = 3 cm inferior from isocenter; TR/TE1/TE2/TE3/TE4/TE5 = 38.1/3.8/7.0/12.3/
19.3/26.3 ms, α = 15°. The superior velocity-encoded dual-echo GRE had the following
2

parameters: FOV = 96 × 96 mm ; keyhole acquired matrix = 96 × 24, (for SvO2 and velocity
analyses, reconstructed matrix = 96 × 96 using a fully sampled reference image); VENC = 120
cm/s; slice thickness = 0.5 cm; slice location = 3-4 cm superior from isocenter; TR/TE1/TE2 =
20.0/6.0/9.7 ms, α = 10°. Flip angle was reduced in the superior multi-echo GRE to mitigate the
potential error in perfusion due to a reduction in the starting magnetization of the blood water
spins prior to NS inversion. Perfusion, bulk flow, SvO2, and T2* each were quantified with foursecond temporal resolution.
4.3.3. Reactive hyperemia protocol
To assess whether vPIVOT is biased in its measurement of each parameter, vPIVOTderived perfusion, SvO2, and T2*, or SvO2 and flow were compared to those obtained with PIVOT
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or OxFlow, respectively. In five healthy subjects (4 male, 32.4±6.4 years old), data were acquired
with each of the three sequences throughout separate ischemia-reperfusion paradigms, each with
2 minutes of baseline, 3 minutes of ischemia, and 4 minutes of recovery.
Average signal intensity was determined for SS and NS EPI data at each time point in
regions of interest (ROIs) in muscles of the calf including: the gastrocnemius muscle, the primary
muscle activated by plantar flexion contraction; the soleus muscle, a postural muscle also
involved in plantar flexion contraction; the peroneus muscles, a group of muscles that are
involved in plantar flexion contraction and eversion of the foot; and the anterior compartment,
comprising the tibialis anterior and extensor digitorum longus muscles, which are primarily
responsible for dorsiflexion. Additionally, signal intensities in all of the ROIs were averaged
together to calculate the average perfusion of the cross-section of the leg. Perfusion was
quantified from the label and temporally-matched control data (see chapter 2 and 3 for details)
using the model proposed by Raynaud, et al (34). As described previously (124), the perfusion
offset was corrected by subtracting the average perfusion during the period of arterial occlusion
from each time point. From the perfusion time courses, the time to peak perfusion and peak
perfusion were determined.
The superior slice was positioned such that it intersected the tibioperoneal trunk, a short
arterial segment distal to the branch point of the anterior tibial artery, before the bifurcation of the
posterior tibial and peroneal arteries. Artery and vein velocities were quantified from the
superiorly located multi-echo GRE data of vPIVOT and were compared to OxFlow-derived
measures from the same slice location. Velocity was averaged over the cross-section of the
artery or vein, and was multiplied by the vessel’s cross-sectional area to derive flow.
Using the susceptometry-based oximetry model (58), SvO2 was quantified for both the
superiorly and inferiorly acquired GRE data in vPIVOT and were compared to OxFlow and
PIVOT, respectively. Hematocrit was not measured in this study, but instead was assumed to be
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0.45 or 0.40 for the male and female subjects, respectively. In the inferior slice, SvO2 was
quantified in the peroneal vein and results were compared to those from PIVOT. In the superior
slice, positive and negative VENC acquisitions were averaged and SvO2 was quantified in the
tibioperoneal vein and results were compared to those from OxFlow. In all cases, the average
baseline SvO2 and the washout time (time to minimum SvO2) was recorded from the dynamic
time course.
From the inferior multi-echo GRE data for both vPIVOT and PIVOT sequences, T2* was
quantified in a ROI in the soleus muscle by fitting the magnitude signal intensities from echoes 25 to a mono-exponential function. T2* was then normalized to the average baseline value, and the
maximum relative T2* (T2*max) and time to peak T2* were determined.

4.3.4. Exercise protocol
The five subjects involved in the reactive hyperemia evaluation plus another five subjects
(7 male, 31.7±5.0 years old) were scanned during a dynamic contraction protocol. vPIVOT data
were acquired continuously throughout 2 minutes baseline, 2 minutes of resisted dynamic plantar
flexion contractions, and 8 minutes recovery. Contractions were performed against the foot pedal
of a custom-built, MRI-compatible ergometer. Subjects were coached to perform one full
contraction and relaxation cycle every second against a pressure of 10 psi, corresponding to 6
watts.
Data analysis for each parameter was the same as for the reactive hyperemia evaluation.
Of note for subjects only involved in the exercise study, vPIVOT data were acquired during a
scan consisting of 2 mins baseline and 2 mins of arterial occlusion to determine the baseline
perfusion offset as described above. In subjects who participated in both the ischemia and
exercise protocols, the baseline offset calculated from the ischemia data were applied. In all
subjects, muscle volume was quantified via manual segmentation from a 3D SSFP-echo
acquisition. Muscle volume was converted to mass using the density of muscle (1.06 g/mL).
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𝑉𝑂! was calculated via the Fick principle (equation [4.1]) using flow measured either from
perfusion (𝑉𝑂!,!"#$ ) or muscle mass-normalized arterial flow (𝑉𝑂!,!"#$ ). In both cases, SaO2 was
assumed to be 100% and thus arteriovenous oxygen difference was estimated as (1-SvO2). Peak
𝑉𝑂! , time to peak 𝑉𝑂! , and net 𝑉𝑂! (total integrated post-exercise area) were recorded for
𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$ .

4.3.5. Statistical analyses
Given the limited sample size, Wilcoxon signed rank tests were used to assess whether
significant differences existed between vPIVOT-measured responses and PIVOT or OxFlow
measures from the reactive hyperemia evaluation. For the exercise evaluation, Wilcoxon-signed
rank tests were also used to assess whether significant differences existed between the time to
peak perfusion and time to peak arterial and venous blood flow, and whether differences existed
between 𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$ peak, time to peak, or net responses.

4.4. Results
4.4.1. Post-ischemia reactive hyperemia evaluation.
Figure 4.2 shows the time courses for the reactive hyperemia experiments from vPIVOT
and comparison sequences. Table 4.1 shows the results of the metrics to parameterize the time
courses from each sequence. Overall, the reactive hyperemia response was not observed to be
significantly different when measured with vPIVOT and PIVOT or OxFlow.
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Figure 4.2. Averaged across all five subjects, vPIVOT reactive hyperemia data
are compared to OxFlow-derived flow and SvO2, and PIVOT-derived perfusion
and T2*. Grey box indicates period of arterial occlusion and error bars indicate
standard error. A significant difference was not observed between vPIVOT and
OxFlow or PIVOT for any of the quantified time course metrics.
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Table 4.1. vPIVOT derived time course metrics are compared to those obtained
with OxFlow or PIVOT. Significant differences between sequences were not
observed for any parameter.

Max venous flow (mL/min)
TTP venous flow (s)
Max arterial flow (mL/min)
TTP arterial flow (s)
Gastrocnemius muscle peak
perfusion (mL/min/100g)

OxFlow

vPIVOT

213 (21)

191 (47)

6 (3)

6 (4)

513 (172)

527 (220)

6 (3)

6 (2)

PIVOT

50 (13)

52 (13)

Gastrocnemius muscle TTP perfusion (s)

20 (6)

18 (9)

Soleus muscle peak
perfusion (mL/min/100g)

42 (17)

44 (19)

Soleus muscle TTP perfusion (s)

14 (6)

15 (7)

Whole-leg average peak
perfusion (mL/min/100g)

40 (12)

41 (12)

Whole-leg average TTP perfusion (s)

13 (7)

16 (7)

Tibioperoneal trunk baseline SvO2 (%HbO2)

70 (8)

70 (14)

Tibioperoneal trunk SvO2 washout time (s)

8 (3)

8(0)

Posterior tibial vein baseline SvO2 (%HbO2)

63 (7)

65 (7)

Posterior tibial vein SvO2 washout time (s)

16 (7)

23 (15)

Soleus muscle relative T2*max (%)

107 (3)

107 (3)

Soleus muscle TTP T2* (s)

30 (7)

30 (8)

Specifically for the arterial velocity time course results, no significant difference was
detected between vPIVOT and OxFlow. Of note, the OxFlow sequence uses full k-space
acquisition for each data point, whereas vPIVOT uses keyhole reconstruction for view sharing.
The interleaved sequence and the keyhole reconstruction did not appear to impact the
quantification of velocity or flow in the artery or the vein. Peak arterial flow was 706±442 mL/min
for vPIVOT and 701±445 mL/min when quantified from OxFlow data. Of note, one subject had
particularly high flow values, which were well represented by both vPIVOT and OxFlow.
Removing the outlying subject’s data, the average was 527±220 mL/min and 513±172 mL/min for
vPIVOT and OxFlow, respectively. Time to peak arterial flow was 6±2 s or 6±3 s for vPIVOT or
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Ox Flow, respectively (P>0.05). Phase contrast data also allows for the quantification of venous
blood flow, and again a difference was not observed between vPIVOT and OxFlow data.
Perfusion metrics were not found to significantly differ when measured with vPIVOT or
PIVOT. In the gastrocnemius muscle, the peak perfusion was 50±13 mL/min/100 g when
measured with vPIVOT, and 52±13 when measured with PIVOT (P>0.05). Time to peak in the
gastrocnemius muscle was 20±6 s and 18±9 s with vPIVOT and PIVOT, respectively. In the
soleus muscle, the peak perfusion was 42±17 mL/min/100g and 44±19 mL/min/100g, and time to
peak was 14±6 and 15±7 seconds when measured with vPIVOT and PIVOT. Again, the Wilcoxon
signed rank test was not significant for differences between vPIVOT and PIVOT.
SvO2 dynamics were not found to differ between vPIVOT and PIVOT in the inferior slice
location, nor did they differ between vPIVOT and OxFlow in the superior slice location. In two
subjects, the peroneal veins were too small, thus in the inferior slice SvO2 could not be measured
with either PIVOT or vPIVOT. In the remaining three subjects, washout time was 16±7 s and
23±15 s. In one subject, (different than the two mentioned previously) changes in SvO2 were not
measured using either OxFlow or vPIVOT in the superior slice. In the remaining four subjects, the
washout time was 8±0 s and 8±3 s for vPIVOT and OxFlow, respectively. A difference was not
observed between the baseline SvO2 for either slice location.
The BOLD response in the soleus muscle was the most delayed in reaching its peak
magnitude for both vPIVOT and vPIVOT (TTPT2* = 30±7 s or 30±8 s for vPIVOT or PIVOT,
respectively). Relative T2* changes were successfully measured in each of the five subjects, and
a significant difference between sequences was not detected (P>0.05). Relative T2*max was
107±3% in vPIVOT and 107±3% in PIVOT as well.
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4.4.2. Post-exercise functional hyperemia investigation
Each subject was coached throughout the two-minute bout of exercise, and plantar
flexion contractions were practiced prior to the scan. However, the precise workload of the
exercise was not quantified for each subject. Although hyperemia was induced by the exercise in
all subjects, two datasets were removed from the final analysis: one because the subject was
incapable of maintaining the 1-second contraction rate, and the other due to substantial motion
during the recovery period following exercise. The remaining eight subjects are included in
subsequent analyses.
Gastrocnemius muscle volume was quantified for each subject from the SSFP-echo
images, which provided contrast between muscle tissue and facial planes and blood, allowing
conspicuity of muscle boundaries. Average gastrocnemius muscle mass was 349±75 g.
Table 4.2 summarizes the results from the exercise protocol, and Figure 4.3 shows the
time course of each of the measured parameters over the course of the scan. Compared to the
response following induced ischemia in which the times to peak perfusion and peak arterial and
venous flow were approximately equivalent, there is a substantial delay in the time to peak
perfusion following exercise. In fact, both arterial flow and venous flow reached their peaks 8±3 s
after cessation of exercise, while gastrocnemius muscle perfusion did not reach its maximum until
101±53 s (p<0.005). Figure 4.4 shows the average perfusion response in each of muscles in the
calf.
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Table 4.2. Synopsis of vPIVOT-measured responses during the dynamic
exercise protocol. * indicates presence of a significant difference between flow
and perfusion responses.
vPIVOT
Max venous flow (mL/min)

463 (149)

TTP venous flow (s)

8 (3)

Max arterial flow (mL/min)

624 (223)

TTP arterial flow (s)

8 (3)

Gastrocnemius muscle peak perfusion (mL/min/100g)

88 (33)

Gastrocnemius muscle TTP perfusion (s)

101 (53)*

Peak 𝑉𝑂!,!"#$ (mL O2/min/100g)

15.2 (6.7)

TTP 𝑉𝑂!,!"#$ (s)

12 (7)

Net 𝑉𝑂!,!"#$ (mL O2/100g)

20.6 (9.7)

Peak 𝑉𝑂!,!"#$ (mL O2/min/100g)

6.0 (1.9)*

TTP 𝑉𝑂!,!"#$ (s)

102 (37)*

Net 𝑉𝑂!,!"#$ (mL O2/100g)

22.3 (13.5)
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Figure 4.3. vPIVOT-measured responses during the dynamic exercise protocol.
The quantified time courses were averaged over the eight subjects, and error
bars indicate standard error. Flow peaked and recovered rather quickly, while
perfusion continued to increase for more than one minute after exercise. The
SvO2 and T2* responses both drop upon relaxation then begin to recover at a
similar rate.
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Figure 4.4. Average exercise vPIVOT-derived perfusion data is shown for
individual muscles. Hyperperfusion is primarily observed in the gastrocnemius.
No substantial response is detected in the soleus or peroneus muscles or in the
muscles of the anterior compartment.
SvO2 was computed for both the superior and inferior slice locations and results were
averaged for use for the quantification of muscle oxygen consumption. Figure 4.5 shows the
calculated 𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$ responses. Similar to the relationship between macrovascular
flow and perfusion, 𝑉𝑂!,!"#$ peaks and recovers quickly, while the 𝑉𝑂!,!"#$ response is more
delayed.

Peak 𝑉𝑂! was significantly different when measured with mass-normalized flow

compared to perfusion: 𝑉𝑂!,!"#$ was 15.2±6.7 mL O2/min/100g while 𝑉𝑂!,!"#$ was 6.0±1.9 mL
O2/min/100g (p<0.005). The time to peak was also significantly different: time to peak 𝑉𝑂!,!"#$
was 12±7 s, and time to peak 𝑉𝑂!,!"#$ was 102±37 s (p<0.01). However, the net 𝑉𝑂! was not
observed to significantly differ. Net 𝑉𝑂!,!"#$ was 20.6±9.7 mL/100g and net 𝑉𝑂!,!"#$ was
22.3±13.5 mL/100g (P>0.05).
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Figure 4.5. 𝑉𝑂! was calculated via the Fick principle using perfusion or massnormalized average arterial flow. The average of eight subjects is shown, with
error bars indicating standard error. Exercise occurred during the grey box from 2
minutes to 4 minutes. Although the peak amplitude and time to peak of the
𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$ are significantly different, the total integrated post-exercise
response is similar.

4.5. Discussion
Overall, vPIVOT was capable of measuring the reactive hyperemia and functional
hyperemia responses. vPIVOT results quantifying the reactive hyperemia response were not
observed to significantly differ from those obtained by the comparison sequences, however the
limited sample size exposes this conclusion to the potential of a Type II error. The dynamic
measurement of the functional hyperemia response of the off-kinetics using vPIVOT may provide
insight into the regulation of blood flow and oxygen consumption in skeletal muscle.
The ability to measure blood flow both in the large arteries and capillary bed provides a
unique method for the investigation of the regulation of blood flow to skeletal muscle. Following
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ischemia, no substantial delay in the perfusion response was detected in these healthy subjects.
During the period of transient ischemia, the terminal arterioles are able to vasodilate both due to
the accumulation of vasodilator metabolites and the reduction in intra-arterial pressure. Upon cuff
release, the return of arterial blood flows to the low-resistance capillary bed resulting in an almost
immediate perfusion. On the other hand, during exercise, there is still a buildup of metabolic
waste products, and a demand for increased oxygen due to increased oxygen utilization.
However, the capillary bed remains a high-resistance structure. Upon relaxation, the
intramuscular pressure drops allowing for the increase in blood flow through the large arteries.
The microvascular response, however, lags as it takes some finite amount of time for the terminal
arterioles to relax due to NO-mediated vasodilation from increases in wall shear stress, as
described in previous chapters. The relationship between the microvasuclar and macrovascular
flow may differ in patients with primary microvascular impairment, such as diabetics.

4.5.1. Post-ischemia reactive hyperemia evaluation
In the present study, vPIVOT was compared to two sequences: OxFlow and PIVOT.
PIVOT was previously evaluated compared to independent PASL and multi-echo GRE
measurements during reactive hyperemia, and no bias was detected between any of these
scans. OxFlow has been proposed as a method for the simultaneous quantification of blood flow
and oxygen saturation and has been applied in both the brain (147-149) and in the peripheral
circulation (88).
The temporal resolution of sampling for both PIVOT and OxFlow were adapted to match
that of vPIVOT, and overall this resulted in a reduction of the sampling rate. PIVOT in its original
implementation had a temporal resolution of 2-seconds for each measurement, compared to the
4-second temporal resolution of vPIVOT. OxFlow’s temporal resolution can be varied, depending
on the specific application. For example, the temporal sampling rate can exceed 2 s through the
application of view-sharing techniques, useful for the measurement of dynamic events (148). Or,
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full images can be acquired when assessing the baseline state, with a temporal resolution of 8-30
s (147,149). In the present study, keyhole reconstruction was used as a view-sharing technique
(122), permitting high apparent spatial resolution from the dynamically acquired data. Each of the
dynamic GRE acquisitions took approximately 1 second.
Of note, none of the acquired GRE data following the non-selective inversion are used in
the analysis, as the inversion impacts all signal within the coil sensitivity. However, it is important
to maintain identical tissue contrast between the label and control conditions for perfusion
quantification, thus the GRE data are still acquired.
To evaluate the combined sequence to the standard measures, post-ischemic reactive
hyperemia was selected as the functional paradigm since relatively good repeatability of the
results has been reported within the same scan session (142). Furthermore, the protocol is
subject-effort independent, and the response is shorter-lived than in the post-exercise active
hyperemia protocol. A recent report from Lopez, et al suggests that post-ischemia reactive
hyperemia is the method of choice for the measurement of vascular reactivity (25). However, 𝑉𝑂!
was not quantified from the reactive hyperemia paradigm due to the fact that the measured
temporal dynamics of oxygen saturation do not reflect the true underlying physiologic response at
the level of the tissue. Rather, the response measured is the aggregate affect from the prior
period of induced ischemia. This can be seen as the T2* continues to drop throughout the period
of proximal arterial occlusion, but SvO2 remains relatively constant during this time.
In the distal peripheral circulation, SvO2 is the most challenging of the PIVOT parameters
to measure due to the size of the vessels in the calf and the potential for compression from the
weight of the calf resting on the coil (134). The measurement of SvO2 at two different slice
locations may improve the chances of acquiring suitable data, especially because veins widen as
they become more proximal to the heart. However, the presence of differences between SvO2
measured at the two different slice locations will require further investigation.

94

The most likely error in vPIVOT would be a reduction in the measured perfusion. During
the superior multi-echo GRE sequence, application of RF excitation pulses proximal to the PASL
measurement site will result in a reduction in the magnetization of blood water spins. Because of
this, the superior GRE data are acquired outside of the PASL sequence so that the label remains
undisturbed. However, the OxFlow interleave will cause a reduction in the magnetization prior to
non-selective (control) inversion, reducing the labeling efficiency, thus resulting in an
underestimation of the measured perfusion. Furthermore, this impact will depend upon the arterial
blood flow velocity, since the number of excitation pulses, and hence the degree of excitation that
each spin will experience is related to the slice thickness and velocity. In vPIVOT, the excitation
flip angle and slice thickness were reduced for the superior GRE acquisition to reduce the
potential error.
It did not appear that the superiorly located excitation pulses substantially impacted the
perfusion quantification, as significant differences between vPIVOT and PIVOT measures were
not detected. Furthermore, reactive hyperemia results are in relative agreement with prior studies.
In comparison to prior investigations, the peak perfusion in the soleus is approximately equal: 42
± 17 mL/min/100g in the present study compared to the results from Chapter 2 where peak
perfusion was found to be 37.0 ± 6.1 mL/min/100g (142). With the pseudo-continuous ASL
technique described in Chapter 3, peak perfusion values of approximately the same magnitude
as those presented herein were measured as well. However, all of these results are much lower
than the peak perfusion in the soleus muscle of 80 ± 31 mL/min/100g reported by Wu, et al using
a continuous ASL technique (47). Comparing whole-leg perfusion to another study, there is
approximate agreement: 40 ± 12 mL/min/100g in the present study compared to Raynaud, et al’s
measurement with the same PASL sequence of 50 ± 13 mL/min/100g (34). In general, the results
presented in this study are also in relative agreement with prior reports of arterial blood flow in the
peripheral circulation (66,88), SvO2 dynamics (66,75,142),
(68,142).
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and the relative response of T2*

4.5.2. Post-exercise functional hyperemia evaluation
In all subjects, a functional hyperemic response was stimulated from the bout of resisted
plantar flexion contractions. Subjects reported that the exercise load was moderate; therefore it is
assumed that muscle pH did not substantially change (although this was not measured). The
average perfusion response was greatest in the gastrocnemius muscle, although some subjects
also had an increase in perfusion in the soleus muscle, another muscle involved in plantar flexion
contraction. The anterior compartment (involved in dorsiflexion) had almost no hyperemic
response for all subjects.
The SvO2 and T2* time courses were not parameterized for the exercise study as they
were for the reactive hyperemia evaluation. The SvO2 washout time may have less physiologic
relevance as the deoxygenated blood during the exercise period is constantly flowing out into the
large draining veins though the rhythmic muscle contractions. There is, however, a slight dip in
the average SvO2 time course upon relaxation. The relative T2* response may help to inform on
the relationship between the oxygen saturation in the draining vein and that in the capillary bed.
As mentioned previously, T2* depends on blood oxygen saturation in the capillary bed as well as
perfusion, vessel orientation, pH, and other factors. The only two of those factors that are
expected to change in this study are oxygen saturation and perfusion. Looking at the relationship
between these three parameters, it is noted that SvO2 and T2* both continue to rise as perfusion
is beginning to drop, perhaps providing evidence that the draining vein SvO2 response may be
used as a surrogate for the capillary bed oxygen saturation for the post-exercise response. This,
however, requires additional investigation.
The discrepancy between the maximum 𝑉𝑂!,!"#$ and 𝑉𝑂!,!"#$ is partially explained by the
fact that bulk flow was normalized only to the gastrocnemius muscle mass, yet the blood flow in
the tibioperoneal trunk supplies other muscles of the calf and foot in addition to other structures.
Based on the perfusion measurements, the hyperemia response seems to be primarily localized
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to the gastrocnemius muscle, however there is an early increase in flow in all of the muscles
around the same time as the macrovascular flow peak. Another reason that 𝑉𝑂!,!"#$ may be
overestimating the true oxygen consumption is due to the presence of non-nutritive flow. Given
that the macrovascular blood flow in the arteries and veins peak simultaneously, this suggests
that there may be substantial non-nutritive flow shunted from the arteries to the veins upon
relaxation.
It is difficult to compare these results to the prior studies mentioned in the introduction for
several reasons. Each study has employed different methods, have varied in their measurement
locations, and have used different exercise protocols including type of exercise and workload.
Compared to Mathewson, et al’s study investigating the off-kinetics in the quadriceps muscles,
the measured peak 𝑉𝑂! was slightly lower, 9.6±1.8 mL/min/100g, however similar to this study,
the response appears to have occurred immediately after cessation of exercise (113). Zheng, et
al reported a 𝑉𝑂! of 3.8±2.5 mL/min/100g and 6.1±2.9 mL/min/100g during two separate
sustained isometric plantar flexion contrations in the calf (115). Even though this result is similar
to the findings of the present study, a direct comparison cannot be made between these two
investigations due to the difference in exercise protocols. Finally, Buck et al’s study, investigating
the off-kinetics used an isometric dorsiflexion contraction for their exercise protocol but only
relative changes in 𝑉𝑂! were quantified (116).
In addition to those explored in the present study, an advantage that vPIVOT provides is
the potential to account for changes in vascular volume during the recovery period following
exercise. As long as there is no change in vascular volume, the arterial inflow and venous outflow
will match, however if there is a change in the vascular volume (e.g. vascular filling), this could
result in an error when quantifying 𝑉𝑂! . With vPIVOT, the arterial inflow and venous outflow are
directly measured, thus the aggregate flow volumes can be quantified and could be used to adapt
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the calculation of 𝑉𝑂! . This was, however, not pursued for the present study, as the goal was to
explore the fidelity and potential of vPIVOT.

4.5.3. Study limitations
There are several limitations to the present study. First, the sample size was limited, thus
although a significant difference between vPIVOT and PIVOT or OxFlow was not detected, there
is potential that a significant difference does exist, but that this study was underpowered to detect
the significant difference.
Additionally, blood flow in the tibioperoneal trunk does not exclusively supply the
gastrocnemius muscle. Blood supply to the soleus and peroneus muscles also stems from the
tibioperoneal trunk. Both of these muscles are also involved in plantar flexion contraction, and the
peroneus muscle also plays a role in eversion of the foot. In addition, the tibioperoneal trunk
provides the vascular supply to some muscles of the foot, and skin, tendons, and other
connective tissue of the calf and foot. Therefore, 𝑉𝑂!,!"#$ will be overestimated since it was
normalized to only the mass of the gastrocnemius muscle. So while the absolute magnitude of
the response may be in error, the temporal response dynamics would not change.
Oxygen saturation was quantified in the large draining veins rather than locally in the
capillary bed. As mentioned earlier in the discussion, there is potential that the relative T2*
response will allow for the investigation of this relationship, however this was not undertaken as a
part of this study. The comparison between 𝑉𝑂! measured with either macrovascular flow or
microvascular perfusion, and with either draining vein SvO2 or R2’-based capillary bed oxygen
saturation would be of great interest.

4.6. Conclusions
In summary, the feasibility of quantification of arterial and venous bulk flow, perfusion,
draining vein SvO2, and skeletal muscle T2* has been demonstrated in healthy volunteers. The
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relationship between macro- and microvascular blood flow was explored following induced
ischemia and dynamic exercise, demonstrating the disparity in primarily the microvascular
response to the two paradigms. The measurement of the relationship between macro- and
microvascular blood flows may be of important clinical significance in patient populations such as
diabetics, or patients with peripheral artery disease. Finally, oxygen consumption was calculated
based on the aggregate measures of perfusion or bulk arterial flow and draining vein SvO2,
allowing for the dynamic measurement of the muscle’s metabolic response following exercise.
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CHAPTER 5: MULTIPARAMETRIC ASSESSMENT OF VASCULAR
FUNCTION IN PERIPHERAL ARTERY DISEASE: DYNAMIC
MEASUREMENT OF SKELETAL MUSCLE PERFUSION, BLOODOXYGEN-LEVEL DEPENDENT SIGNAL, AND VENOUS OXYGEN
SATURATION
5.1. Abstract
Background – Endothelial dysfunction present in patients with peripheral artery disease (PAD)
may be better understood by measuring the temporal dynamics of blood flow and oxygen
saturation during reactive hyperemia than by conventional static measurements.
Methods and Results – Perfusion, Intravascular Venous Oxygen saturation, and T2* (PIVOT), a
recently developed MRI technique, was used to measure the response to an ischemiareperfusion paradigm in ninety-six patients with PAD of varying severity, and ten healthy controls.
Perfusion, venous oxygen saturation (SvO2), and T2* were each quantified in the calf at two
second temporal resolution, yielding a dynamic time course for each variable. Compared to
healthy controls, patients had a blunted and delayed hyperemic response. Moreover, patients
with lower ankle-brachial index had: 1) a more delayed reactive hyperemia response time,
manifesting as an increase in time to peak perfusion in the gastrocnemius, soleus, and peroneus
muscles, and in the anterior compartment; 2) an increase in the time to peak T2* measured in the
soleus muscle; and 3) a prolongation of the posterior tibial vein SvO2 washout time. Intra- and
inter-session repeatability was also assessed. Results indicated that time to peak perfusion and
time to peak T2* were the most reliable extracted time course metrics.
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Conclusions – Perfusion, dynamic SvO2, and T2* response times following induced ischemia are
highly correlated with PAD disease severity. Combined imaging of peripheral microvascular blood
flow and dynamics of oxygen saturation with PIVOT may be a useful tool to investigate the
pathophysiology of PAD.

5.2. Introduction
Peripheral artery disease (PAD) is most commonly a manifestation of atherosclerosis in vessels
supplying the lower limbs, and causes significant morbidity and mortality in the United States (1113,150). In PAD, atherosclerotic plaque encroaches on the peripheral artery lumen, decreasing
blood flow and vascular reactivity of the large arteries (15,151). Collateral arteries vasodilate in
order to meet the baseline metabolic demand of skeletal muscle; however as described in the
preceding chapters, the collateral vasculature may be inadequate to quickly and adaptively
accommodate increases in blood flow demand, such as those that occur during exercise (16).
This effect can result in an oxygen supply-demand mismatch, causing patients to experience
claudication (150).
The presence of flow-limiting stenoses can be quickly and non-invasively detected by
measuring the ankle-brachial index (ABI), the ratio of systolic blood pressures in the ankle and
brachial artery (150,152). An ABI of less than 0.9 confirms the diagnosis of PAD, and an ABI of
less than 0.4 is suggestive of critical limb ischemia (150,153). Interventions such as cilostazol
(22) or exercise rehabilitation (21) lessen claudication symptomatology, however are not
necessarily associated with a clinically significant improvement in the ABI. Additionally, the ABI is
not sensitive to primary microvascular impairment, endothelial dysfunction, or alterations in
vascular reactivity that may coexist with the macrovascular lesions (15,154). Thus, there is a
compelling need for the development of diagnostic tools that would allow for the interrogation of
the contribution of vascular dysfunction to PAD.
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As detailed in prior chapters, peripheral vascular function can be interrogated by
monitoring the dynamics of blood flow and oxygenation in response to a stressor, analogous to
cardiac stress testing. Several magnetic resonance imaging (MRI) techniques can non-invasively
evaluate the dynamic changes that occur in blood flow and oxygenation during the hyperemic
response. Specifically, prior studies have investigated perfusion using arterial spin labeling (ASL)
(34,47,155), dynamics of SvO2 using MR susceptometry-based oximetry (58,67), and changes in
the T2* signal (commonly known as blood-oxygen-level dependent (BOLD) response)
(68,69,156), which provides a relative measure of muscle capillary bed oxygenation (62,63). In
response to induced ischemia, an alteration in the response dynamics of each of these variables
is associated with the presence of PAD. Compared to healthy controls, patients exhibit a blunted
and delayed reperfusion (52), and a reduced rate of recovery of tissue oxygenation, as evidenced
by both direct measurement of SvO2 (66,67), and of relative changes in T2* (68).
In Chapter 2, we developed a technique termed Perfusion, Intravascular Venous Oxygen
saturation, and T2* (PIVOT) which allows for dynamic and simultaneous quantification of
perfusion, SvO2, and skeletal muscle T2* (142). The purpose of this work was to evaluate the
hyperemic response in patients with PAD and healthy controls using PIVOT. We hypothesize that
PIVOT will be able to detect PAD severity-dependent changes in macro- and microvascular
function, and that the relationship between these impairments will help us to better understand
the pathophysiologic processes that underlie the disease.

5.3. Methods
5.3.1. Subjects
Ninety-six patients with intermittent claudication and a diagnosis of PAD and ten healthy
controls were recruited to participate in the study. Upon enrollment, each subject was classified
into a disease severity group based on ABI, where healthy subjects had an ABI > 0.90 (10
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subjects; 3 males), mild disease corresponded to an ABI range of 0.7 – 0.89 (28 patients; 18
males); moderate disease to an ABI range of 0.50 – 0.69 (45 patients; 28 males); and severe
disease to an ABI of less than 0.50 (17 patients; 13 males). Additional characteristics of the study
participants are shown in Table 5.1.

Table 5.1. Characteristics of study participants.
Healthy
ABI>0.9

Mild
ABI 0.7 to
0.89

Moderate
ABI 0.5 to
0.69

Severe
ABI<0.5

All patients
ABI<0.9

Total
10
28
49
19
96
Repeat visit
9
11
23
8
42
Gender (M/F)
3/7 *
18/10
29/20
15/4
62/34
Age
59.5 (3.9) *
66.8 (6.3)
69.4 (8.1)
71.3 (8.6)
69.0 (7.8)
BMI
26.2 (4.9)
27/6 (3.9)
27.4 (4.0)
27.5 (4.0)
27.5 (3.9)
Systolic BP
123 (21) *
142 (18)
141 (19)
137 (17)
141 (18)
Diabetes
0*
10
15
6
31
Smoking status
(Never/Past/
5/5/0 *
2/19/7
4/32/13
2/7/10
8/58/30
Current)
Mean (standard deviation) or counts are shown. * Indicates a significant difference between
healthy subjects and all PAD patients.

5.3.2. Experimental Protocol
Prior to participation in the study, each subject provided written informed consent. The
Institutional Review Board of the University of Pennsylvania approved all aspects of this study.
PAD patient protocol: Each patient reported to the testing center for two separate visits no more
than one month apart. Some subjects were selected to return for a third visit, approximately three
months after the second. On the first visit, screening and medical history questionnaires were
completed, and the ABI was measured bilaterally using Doppler sonography according to the
current standards (157). Patients were instructed to refrain from strenuous exercise for 3 days
prior to the second visit, and to avoid alcohol and caffeine for 24 hours prior. Upon reporting for
the second visit, patients underwent a vascular function MRI scanning session. The MRI protocol
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consisted of dynamic imaging of blood flow and oxygenation of the mid-calf using PIVOT
throughout an ischemia-reperfusion paradigm. If selected to return, the third visit was identical to
the second.
Healthy subject protocol: Healthy subjects reported to the testing center for two identical visits,
separated by 1 day to 1 week. Each MRI session included two identical PIVOT scans throughout
periods of ischemia-reperfusion.

5.3.3. MRI Scan Protocol
All imaging was performed on a 3T MR imaging system (Siemens, Erlangen, Germany).
For every patient, the leg with the lower ABI was scanned, and for each healthy control, the right
leg was scanned. The maximum girth of the calf was centered in an 8-channel transmit-receive
knee coil (In vivo, Inc. Gainesville, FL). PIVOT data were continuously collected throughout one
minute of baseline, five minutes of proximal arterial occlusion, and six minutes following cuff
deflation. Proximal arterial occlusion was achieved using a pneumatic tourniquet system
(Hokanson, Inc., Bellevue, WA) with a cuff placed on the mid-thigh. After one minute of baseline
scanning, the cuff was rapidly inflated to 75 mmHg above the measured systolic blood pressure,
or 250 mmHg, whichever was lower. For all healthy subjects, the ischemia-reperfusion paradigm
was repeated within the same scan session to assess intra-session repeatability.
As described previously (142), PIVOT allows for continuous, simultaneous measurement
of perfusion, intravascular SvO2, and skeletal muscle T2* using an interleaved dual-slice pulsed
ASL (PASL) and multi-echo GRE sequence. Briefly, perfusion quantification is accomplished
using SATuration Inversion-Recovery (SATIR) (34), a Flow-Alternating Inversion Recovery (FAIR)
ASL variant, in which slice-selective and non-selective adiabatic inversion pulses are used to
achieve label and control conditions, respectively. Image acquisition follows the post-labeling
delay (PLD), which is immediately followed by a slice-selective saturation pulse to reset the
magnetization. In PIVOT, a keyhole (122) RF-spoiled multi-echo GRE sequence acquires data at
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a slice located downstream from the PASL slice during the PLD. Only multi-echo GRE data
acquired during the PLD following the slice-selective inversion are used for SvO2 and T2*
analysis, however the multi-echo GRE interleave was run during every PLD to control for
potential magnetization transfer effects. From these data, SvO2 is derived using susceptometrybased oximetry (58,67), and T2* is calculated by fitting the signal magnitude to a
monoexponential function.
For the PASL interleave, images were acquired with the following parameters: partial2

Fourier GRE-EPI readout; field of view (FOV) = 250 × 250 mm ; acquired matrix = 80 × 50,
reconstructed to 80 × 80; slice thickness = 1 cm; slice location = isocenter; TR/TE = 1 s/8.05 ms;
PLD = 952 ms. For the multi-echo GRE interleave, images were acquired with: FOV = 96 × 96
2

mm ; keyhole acquired matrix = 96 × 24, slice thickness = 1 cm; slice location = 3 cm distal from
isocenter; TR/TE1/TE2/TE3/TE4/TE5 = 38.12/3.78/6.99/12.32/19.32/26.32 ms. For SvO2 data
analysis, the acquired matrix was keyhole (122) reconstructed to 96 × 96 pixels using outer kspace data from a fully sampled reference image obtained immediately after the dynamic PIVOT
acquisition; only dynamic data were used for T2* analysis. Each variable was quantified at 2second temporal resolution.

5.3.4. Image Analysis
Image analysis was performed using MATLAB (The MathWorks, Inc., Natick, MA). Prior
to data processing, the time series of images were motion corrected with rigid-body
transformations using NIH ImageJ software (developed by Wayne Rasbands, National Institutes
of Health, Bethesda, MD). Perfusion was quantified in regions of interest (ROIs) in the
gastrocnemius, soleus, and peroneus muscles, as well as in the anterior compartment (AC) –
which includes the tibialis anterior and extensor digitorum longus muscles (Figure 5.1a). For the
assessment of repeatability, a whole-leg ROI was used, which comprised of all four muscle
groups. As described previously (142), an ROI was delineated in the muscle of interest using a
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high-resolution scout image as a reference for muscle boundaries. The average signal-intensity in
the defined ROI following slice-selective (MSS) or non-selective (MNS) inversion was determined.
Using the model described by Raynaud, et al, (34) perfusion (f, in mL/min/100g) was quantified
for each label-control pair as:
!

!!! !!!"

!

!!! !!!"

f = − ⋅ ln

⋅ 1−e

!

!!

+1

[5.1]

where λ is the tissue-partition coefficient (λ=0.9 mL/g), T is the post-labeling delay, T1 is the
longitudinal relaxation time of blood, which in this model is assumed to be equivalent to that of
tissue (T1 = T1muscle = 1420 ms (126) ≈ T1blood). The perfusion offset was corrected by subtracting
the average perfusion during the period of cuff occlusion from each time point, as perfusion is
assumed to be zero during the period of proximal arterial occlusion (124). For each muscle, the
peak perfusion and time to peak perfusion (TTPPerf) were recorded from the dynamic time course
data (Figure 5.1c).
Using the first two echoes of the multi-echo GRE, SvO2 was quantified in the larger
posterior tibial vein (Figure 5.1b). As described previously (67), SvO2 was calculated by
measuring the difference in phase accrual (Δφ) between echoes spaced apart by ΔTE in the
blood versus surrounding reference tissue as:

%𝑆𝑣𝑂! = 1 −

!⋅∆! ∆!"
!!!!" ⋅!"#⋅!! !"#! !!! !

×100

[5.2]

where γ is the proton gyromagnetic ratio, Δχdo the susceptibility difference between fully
oxygenated and deoxygenated blood (Δχdo = 4p∙0.27 ppm (96,97)), Hct the hematocrit measured
by venipuncture, B0 the main magnetic field strength, and q the angle of the vessel with respect to
B0 (measured from axial scout images). The washout time, equal to the time between cuff release
and the minimum SvO2, and the upslope, calculated as the maximum slope during recovery, were
recorded (Figure 5.1d).
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T2* was measured within an ROI in the soleus muscle (Figure 5.1b) by fitting multi-echo
GRE data from echoes 2-5 to a monoexponential function. Signal intensity in the ROI was first
averaged for each echo, then the data were fit to a monoexponential function and T2* was
computed at each time point. The T2* time course data were normalized to the average baseline
value, and relative T2*max, and time to peak T2* (TTPT2*) were recorded from the time course
(Figure 5.1e).

Figure 5.1. Anatomic images corresponding to PASL (a) and multi-echo GRE (b)
slice locations. As shown in (a), perfusion is quantified in regions of interest in the
gastrocnemius (red), soleus (purple), peroneus (orange), and anterior
compartment (AC) (yellow). From the multi-echo GRE data, SvO2 is quantified in
the larger posterior tibial vein (blue arrow), and T2* is calculated from a region of
interest in the soleus (green) shown in (b). Each variable is quantified every two
seconds, yielding a dynamic time course. Schematics of the perfusion (c), SvO2
(d), and T2* (e) time courses are shown, with the extracted metrics indicated. The
grey box in c-e indicates the period of proximal arterial occlusion.
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5.3.4. Statistical Analysis
®

All statistical analyses were performed with JMP software (JMP , Version 11. SAS
Institute Inc., Cary, NC). Data normality was evaluated using the Shapiro-Wilk test. For data from
the normal or log-normal distribution, two-sample Student’s t-tests with equal variance were used
to determine whether differences existed between healthy subjects (ABI ≥ 0.9) and patients with
PAD (ABI < 0.9). Non-parametric Wilcoxon rank tests were used to assess differences of nonnormally distributed variables. In patients with PAD, correlations between the ABI and each time
course metric and between pairs of time course metrics were calculated using Pearson’s
correlation coefficient (if data were normally distributed) or Spearman’s rank correlation
coefficient (if data were not normally distributed). Holm’s adjustment for multiple comparisons
was applied to all tests and correlations to maintain the family-wise error rate of 0.05. Thus, for all
tests, pholms < 0.05 was considered to be significant.
In healthy controls, intra-session and inter-session (1 day to 1 week between scans)
repeatability was assessed. Inter-session repeatability was also assessed in a subset of patients
with PAD (approximately 3 months between scans). In all cases, the intraclass correlation
coefficients (ICC) and mean within-subject coefficients of variation (CVW) were calculated to
assess measurement repeatability.

5.4. Results
5.4.1. Subject Demographics
In six subjects, a cuff pressure of 75 mmHg above systolic blood pressure did not result
in a full occlusion, likely due to calcification of the feeding arteries. Insufficient occlusion was
determined based on appearance of venous pooling in the EPI images and T2* time course. In
the remaining 100 subjects, several subjects’ MRI images were unanalyzable due to motion
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contamination, partial volume effects, low SNR, or insufficient vein size. Table 5.2 shows the
number of patients for each variable that were of sufficient quality for analysis. Notably, for all
subjects in whom a full occlusion was achieved, at least one variable was fit for analysis.

Table 5.2. Synopsis of number of subjects with analyzable images for each
measured variable.
Healthy
ABI>0.9

Mild
ABI 0.7 to 0.89

Moderate
ABI 0.5 to 0.69

Severe
ABI<0.5

All patients
ABI<0.9

Total

10

27

45

18

100

Gastrocnemius Perfusion
Soleus Perfusion
Peroneus Perfusion
AC Perfusion
SvO2

10
10
10
10
10

26
26
25
23
20

40
41
40
36
34

15
14
9
13
13

91
91
84
82
77

Relative T2*

10

27

44

18
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5.4.2. Visualization of MRI time courses
For visualization purposes, average time courses were generated for all healthy subjects and
patients with mild, moderate, and severe PAD disease burden for perfusion in the gastrocnemius
muscle (Figure 5.2a), posterior tibial vein SvO2 (Figure 5.2b), and relative T2* in the soleus
muscle (Figure 5.2c). The typical ischemia-hyperemia response is seen in each variable’s time
course. During the period of arterial occlusion, T2* decreases as the stagnant blood in the
capillary bed becomes increasingly desaturated. After cuff release, SvO2 initially drops as the
deoxygenated blood from the capillary bed advances into the large draining veins in the
measurement slice. Concurrently, perfusion increases in order to repay the oxygen debt incurred
during the ischemic period. This hyperperfusion of oxygenated blood causes T2* and SvO2 to
recover and surpass their baseline values. As blood flow and venous oxygen saturation
normalize, so too does T2*. From the average time courses a striking difference is seen between
healthy subjects and patients with PAD, and furthermore, TTPPerf, washout time, and TTPT2* are
increasingly prolonged as disease severity worsens.
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Figure 5.2. Group-average time courses for healthy subjects (grey), and patients
with mild (light colored), moderate (medium colored), and severe (dark colored)
PAD for gastrocnemius muscle perfusion (a), posterior tibial vein SvO2 (b), and
relative T2* in the soleus muscle (c). Grey box indicates the period of proximal
arterial occlusion. With increasing disease severity, there is a delay in the
reactive hyperemia response evident in each variable that was measured.
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5.4.3. Comparison between healthy subjects and patients with PAD
The group-wise average (standard deviation) of each time course metric for the
measured variables are summarized in Table 5.3. TTPPerf in the peroneus, T2*max, and TTPT2*
were not from the normal distribution, all other variables were from the log-normal distribution.
Each variable, with the exception of SvO2 upslope, was significantly different between healthy
controls and patients with PAD. With the presence of PAD, there was a significant prolongation of
the hyperemic response time, and a reduction in the magnitude of the hyperemic response. SvO2
washout time increased from 11 s in healthy subjects to 39 s in PAD patients. TTPPerf was
delayed as well – averaged over all muscle groups it increased from 24 s to 72 s in patients with
disease. Peak perfusion decreased from 52.6 mL/min/100g to 25.6 mL/min/100g with disease.
TTPT2* in the soleus muscle increased from 33 s to 91 s between healthy subjects and PAD
patients, and relative T2*max decreased from 110% to 106%. Averaged (standard deviation) over
all subjects, baseline T2* was 19 (2) ms, and averaged across all muscle groups the perfusion
offset during ischemia was 7.6 (2.7) mL/min/100g.

Table 5.3. Associations of the presence of PAD with PIVOT time course metrics.
Healthy
ABI > 0.9
(n = 10)

Patients with PAD
ABI <0.9
(n = 90)

ABI

1.11 (0.10)

0.60 (0.14) *

Gastrocnemius Peak Perfusion (mL/min/100g)
Gastrocnemius TTPPerf (s)
Soleus Peak Perfusion (mL/min/100g)
Soleus TTPPerf (s)
Peroneus Peak Perfusion (mL/min/100g)

54.0 (14.5)
29 (10)
74.9 (33.0)
25 (13)
41.2 (11.3)

28.3 (12.9) *
77 (53) *
28.9 (13.9) *
72 (49) *
20.8 (12.4) *

24 (9)

74 (47) *

Peroneus TTPPerf (s)
AC Peak Perfusion (mL/min/100g)

43.4 (16.0)

24.5 (14.1) †

AC TTPPerf (s)

16 (5)

64 (50) *

Washout time (s)

11 (4)

39 (23) *

0.91 (0.40)

0.51 (0.22)

T2*max (%)

111 (4)

106 (3) ‡

TTPT2* (s)

35 (12)

91 (55) *

Upslope (%HbO2/s)

*pholms <0.001; †pholms <0.01; ‡pholms <0.05;
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5.4.4. Inter-variable correlations in patients with PAD
Inter-variable correlations were assessed in PAD patients only. The correlations between
ABI and time course metrics reinforce some of the findings from the group-wise analysis. A
significant correlation was found between the ABI and response time following cuff release
(Figure 5.3 a, c, e). As the ABI decreases, an increase in the time to peak perfusion in all
muscles (gastrocnemius r = -0.60, pholms<0.0001; soleus r = -0.66, pholms<0.0001; peroneus r = 0.43, pholms<0.0001; TA r = -0.55, pholms<0.0001), an increase in the time to peak T2* (r = -0.55,
pholms<0.0001), and an increase in the washout time (r = -0.59, pholms<0.0001) were observed.
However, no statistically significant correlation was detected between ABI and peak perfusion (r =
0.08), SvO2 upslope (r = 0.14), or T2*max (r = -0.04) (Figure 5.3 b, d, f).
In addition to the negative correlation between the hyperemic response time and ABI,
significant positive correlations were detected between most pairs of timing metrics. For example,
as TTPPerf in the gastrocnemius muscle increased, so too did TTPPerf in the other muscles
(averaged over all muscle ROIs, r = 0.71, pholms<0.0001), TTPT2* in the soleus (r = 0.57; p
holms<0.0001),

and SvO2 washout time (r = 0.53; p

holms<0.0001).

The single exception was the

lack of a correlation between the peroneus TTPPerf and SvO2 washout time (r = 0.26). Positive
correlations were also detected between peak perfusion measured in the gastrocnemius and
soleus (r = 0.53; pholms<0.0001) or anterior compartment (r = 0.40; pholms<0.02). The other
significant correlation detected was between relative T2*max and TTPPerf in the peroneus (r=0.43;
pholms<0.005).
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Figure 5.3. Correlation plots for ABI versus gastrocnemius muscle time to peak
perfusion (a) and peak perfusion (b), SvO2 washout time (c) and upslope (d), and
time to peak T2* (e) and relative T2*max (f) measured in the soleus. As disease
severity worsens, the reactive hyperemia response time is progressively
prolonged. However, no correlation was observed between the magnitude of the
hyperemic response and the ABI.
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5.4.5. Repeatability of reactive hyperemia response
In healthy subjects, both intra-session and inter-session repeatability were assessed
(Tables 5.4 and 5.5). The intra-session ICC was greater than 0.7 for all measured variables, with
the exception of TTPT2* (r = 0.61). One healthy subject was lost to follow-up, thus the number of
healthy subjects in whom inter-session repeatability was assessed was 9. Though lower than
intra-session repeatability, the inter-session repeatability in the healthy subjects was still high for
peak perfusion (r = 0.84) and time to peak perfusion (r = 0.74). The ICC, however, was lower for
SvO2 upslope and washout time, T2*max, and TTPT2*. In all cases, the mean within-subject CV in
healthy subjects was less than 25%. In patients with PAD, the ICCs of the perfusion time course
metrics and TTPT2* were approximately equal to or better than the ICC of the ABI measurement (r
= 0.53). The ICC for the SvO2 washout time and upslope, and T2*max, however, was low (r < 0.35).
The mean within-subject CV in patients with PAD was approximately 10% greater than in healthy
subjects for all measured variables.

Table 5.4. Assessment of intrasession repeatability in healthy subjects.
Scan A

Scan B

ICC

CVw

51.5 (13.5)

51.6 (14.3)

0.95

4.1%

Leg TTPPerf (s)

23 (8)

21 (7)

0.76

11.0%

Washout time (s)

11 (4)

11 (5)

0.90

8.8%

Upslope (%HbO2/s)

0.9 (0.4)

0.9 (0.5)

0.79

18.5%

T2*max (%)

111 (4)

112 (4)

0.78

1.1%

TTPT2*

35 (12)

35 (11)

0.61

15.3%

Healthy subjects
Leg Peak Perfusion (mL/min/100g)

TTP indicates time to peak.
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Table 5.5. Assessment of intersession repeatability in healthy subjects and
patients with PAD.
Session 1

Session 2

ICC

CVw

52.1 (14.2)

50.3 (17.1)

0.78

11.8%

Leg TTPPerf (s)

23 (8)

21 (7)

0.71

10.9%

Washout time (s)

12 (4)

14 (9)

0.61

23.4%

Upslope (%HbO2/s)

0.9 (0.5)

0.8 (0.4)

0.57

24.4%

T2*max (%)

111 (4)

110 (3)

0.58

2.0%

TTPT2*

37 (12)

36 (12)

0.58

16.5%

ABI

0.59 (0.15)

0.59 (0.17)

0.53

11.8%

Leg Peak Perfusion (mL/min/100g)

23.3 (8.9)

35.5 (9.5)

0.52

20.3%

Leg TTPPerf (s)

68 (42)

72 (44)

0.78

22.0%

Washout time (s)

34 (17)

30 (16)

0.13

31.9%

Upslope (%HbO2/s)

0.5 (0.2)

0.7 (0.4)

0.08

36.7%

T2*max (%)

106 (3)

106 (3)

0.33

1.9%

TTPT2*

90 (49)

84 (39)

0.57

23.4%

Healthy subjects
Leg Peak Perfusion (mL/min/100g)

Patients with PAD

ABI indicates ankle-brachial index; PAD, peripheral artery disease; and TTP, time to peak.

5.5. Discussion
5.5.1. Synopsis of Results
In this study, peripheral vascular function was investigated in patients with PAD and
healthy controls using PIVOT, a recently developed MRI technique, allowing for simultaneous
measurement of the dynamics of blood flow and oxygen saturation throughout an ischemiareperfusion paradigm. Compared to healthy controls, PAD patients exhibited a blunted and
delayed hyperemic response, as measured by perfusion, SvO2, and T2*. Moreover, the results
showed a significant correlation between PAD disease severity and the temporal dynamics of
recovery of blood flow and oxygenation following induced ischemia. With decreasing ABI, the
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time required to accommodate the hyperperfusion of oxygen-rich blood to the ischemic muscle
was prolonged; there was an increase in the time needed for desaturated blood to flow out of the
capillary bed into the large draining veins; and a delay in the time to peak T2*, indicating a
decrease in the rate of recovery of oxygen saturation in the capillary bed. These data are thus
suggestive of disease-severity-dependent impairment of vascular function in PAD.

5.5.2. Comparison to prior studies of muscle perfusion in PAD
Previous studies have used an ischemia-reperfusion model to investigate peripheral
vascular function in patients with PAD compared to healthy controls, however these studies were
limited to the measurement of a single variable – perfusion(52) or T2* (68), or two variables –
SvO2 and bulk arterial blood flow (66,67). Separately measuring all of the variables in a single
study would require multiple scans. However, with PIVOT, perfusion, SvO2, and T2* are
measured simultaneously, allowing for the direct investigation of the temporal relationships
between perfusion, oxygen saturation, and T2* at no additional scan time or patient discomfort.
PIVOT was previously evaluated by comparing results from PIVOT to those obtained with the
traditional PASL or multi-echo GRE sequences in a cohort of young healthy subjects. No bias
was detected between PIVOT and the individual measurement methods, suggesting that the
simultaneous measurement of perfusion, SvO2, and T2* at high temporal resolution is possible
with PIVOT (142).
Data in the present study show that the temporal dynamics during reactive hyperemia are
associated with the presence of PAD and are tightly correlated with disease severity, thus high
temporal resolution sampling of the response is extremely important. PIVOT provides 2-second
temporal resolution of each of the measured variables, higher sampling rate than prior studies
investigating perfusion alone (16-second temporal resolution) (47,52), or SvO2 and bulk arterial
flow (5-second temporal resolution of SvO2) (66). Temporal resolution of 1-second was used in
previous studies investigating only T2* in skeletal muscle (68,127).
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Unlike perfusion and SvO2, the origin of the BOLD signal is less physiologically
straightforward. BOLD signal depends upon blood oxygenation in the capillary bed, as well as
microvascular flow, blood volume, cellular pH, and vessel diameter and orientation (63). So, while
relative T2* can be quickly acquired, and in this study was the easiest variable to measure
(relative T2* was analyzable in 99/100 subjects), the multifactorial contrast mechanism and the
fact that the measured response is relative, rather than in physiologic units, makes the
interpretation of the BOLD signal more complicated. To reduce potential confounds due to blood
volume on the measured T2*, care was taken to ensure that the patient’s leg was at heart height,
and each patient was supine for approximately 15 minutes prior to the onset of ischemia (51).
Additionally, arterial occlusion was induced using a pneumatic tourniquet system capable of fully
inflating in approximately 0.3 second, thus occluding venous and arterial flow nearly
simultaneously.
Hyperemia can also be induced via exercise rather than induced ischemia. Exercise is
more physiologically relevant to PAD, however muscles may be stressed to varying degrees,
depending on which muscle group is activated (e.g. plantar flexion vs. dorsiflexion), and total
work is subject-effort dependent. Conversely, tourniquet-induced ischemia is a global stimulus,
more uniformly affecting all muscle groups downstream from the site of inflation, and more
consistent between subjects.
A prior study by Wu, et al measured post-ischemic skeletal muscle perfusion with a
continuous ASL (CASL) technique in patients with PAD and healthy controls (52). Compared to
the results from this study, there is good agreement in the trend of timing of the hyperemic
response and disease severity – with the presence of PAD, and with increasing disease severity,
the time to peak perfusion is progressively prolonged (52). Wu, et al also found an association
between the peak perfusion and disease severity (52), whereas in this study an association
between peak perfusion and disease presence, but not severity was detected. CASL provides
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higher signal-to-noise ratio of the perfusion signal at the cost of lower temporal resolution (16
seconds with CASL (52) compared to 2 seconds in this study). As such, relative to this study
much higher peak perfusions were observed in Wu, et al’s investigation for all disease severity
subgroups. For instance, in the gastrocnemius muscle, peak perfusion of approximately 60
mL/min/100g was reported in patients with PAD, compared to 28.3 mL/min/100g reported in the
present study. Using an invasive, but highly precise method, Lassen, et al investigated the
clearance rate of radioactive xenon-133 to determine perfusion in patients and healthy controls
(35). In that study, the reported peak perfusion and time to peak perfusion are in agreement with
the results of the present study – 51.8 mL/min/100g versus 17.1 mL/min/100g, and 22 s versus
138 s for healthy subjects versus patients, respectively. Prior studies investigating perfusion in
young healthy subjects using the same PASL variant, either SATIR alone (34,51) or using the
combined PIVOT technique (142), found peak perfusion during reactive hyperemia to be similar
to those values reported in the present work.

5.5.3. Comparison to prior studies of dynamic oximetry in PAD
Results of intravascular SvO2 measured in the posterior tibial vein are in relative
agreement with Langham, et al’s work investigating SvO2 in the femoral vein of PAD patients
compared to young healthy subjects and age-matched healthy controls (66). As in the results of
this study, Langham, et al reported a prolonged washout time in patients with PAD compared to
their healthy peers. In the present study, a correlation between the ABI and washout time in the
posterior tibial vein was additionally detected. Langham, et al also observed a reduction in
upslope in patients compared to controls, which was not observed in this study. This deviation
could be attributed to the different vessels investigated by the two studies – posterior tibial vein in
this study, compared to the larger and more superior femoral vein in the work by Langham, et al
A larger vein would result in higher signal-to-noise ratio of the measured SvO2, thereby increasing
measurement precision. In this study, it was necessary to acquire SvO2 data downstream from

118

the perfusion measurement location so as to not disturb the magnetization of inflowing blood.

5.5.4. Comparison to prior studies of muscle BOLD in PAD
Finally, the present results are in general agreement with previous BOLD studies in the
leg (68,127). The average T2*max of patients with PAD of 106% is slightly lower than the relative
T2*max of 110.5% reported by Ledermann, et al (68). However, these authors normalized T2* to
the average T2* value of the first 3 seconds following cuff release, whereas for the present study,
T2* was normalized to the baseline average T2*. T2* decreases during the ischemic period,
therefore normalizing the data to the post-ischemic period would increase the T2* range and thus
increase the relative T2*max. In agreement with Ledermann et al’s study, the current study showed
that with decreasing ABI there is an increase in TTPT2*.

5.5.5. Inter-variable correlations
The inter-variable correlations were investigated to better understand the relationship
between blood flow and oxygenation in the capillary bed and large draining veins. Strong positive
correlations were detected between the various timing metrics, however, no significant
correlations were observed between the response time and response magnitude (e.g. peak
perfusion in the gastrocnemius muscle was not significantly correlated with its time to peak
perfusion).
In addition to the benefit of assessing inter-variable relationships, the acquisition of
simultaneous perfusion, SvO2, and T2* measurements with PIVOT increases the likelihood that at
least one of the variables is of sufficient quality for analysis. For example, if a patient has a very
small posterior tibial vein, the measure of SvO2 would not be possible. However, perfusion and
T2* data could still be used to investigate the hyperemic response. Alternatively, in some patients
perfusion was very noisy due to partial-volume effects from unperfused intramuscular fibrous
inclusions. Yet the T2* and SvO2 data were still able to provide insight into vascular function. In
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the present study, though only 71 subjects had analyzable images for all three variables, in all
100 subjects in whom a complete cuff occlusion was achieved, at least one of the variables was
fit for analysis.
The dynamics of the hyperemic response are a function of upstream arterial occlusions,
diffuse atherosclerosis, and endothelium-mediated vascular reactivity. Thus, the assessment of
the response with several variables provides complementary, rather than independent
information. The combination of results from perfusion and SvO2 could, for example, be used to
investigate the relative metabolic response. Furthermore, by modeling the combined PIVOT data,
there may be added sensitivity to detect a response to a therapeutic intervention.

5.5.6. Short-term and long-term repeatability of the reactive hyperemia response
The intra-session repeatability in healthy subjects shows that the measured time course
metrics have excellent precision in the short term. The hyperemic response measured for relative
T2* had a broad peak, unlike the sharp peak of the perfusion measurement (as shown in Figure
5.2). The TTPT2* was, therefore, more sensitive to time course noise than TTP perfusion, resulting
in a reduction in repeatability. This pattern was observed for both intra- and inter-session
repeatability. Compared to intra-session repeatability, inter-session repeatability was slightly
lower. However, it is likely that there are true differences in the reactive hyperemia response due
to normal physiologic variation. Care was taken to minimize known factors that impact vascular
reactivity - all subjects were instructed to refrain from caffeine intake and vigorous exercise prior
to scanning, and scans were conducted at the same time of day. The measured differences are,
therefore, a combination of true physiologic variation, measurement error (as is present for intrasession repeatability), and due to the potential impact of slight changes in slice location.
Generally, the within-subject CV was still quite small, and similar to the reported results in a
previous investigation of inter- and intra-session repeatability of PIVOT-derived time course
metrics in young healthy subjects (142).
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The inter-session repeatability in patients with PAD was acceptable for some variables,
and poor for others (SvO2 washout time and upslope, and T2*max). Overall, the variables were
similarly repeatable in healthy subjects and patients with PAD. Given that the ABI measurement
differed between the two scan sessions, there may be true pathophysiologic progression or
regression of disease in some patients. The ICCs of peak perfusion, TTP perfusion and TTPT2*
were on the order of the ICC of the ABI measurement. The relatively low within-subject coefficient
of variation suggests that although the measured response may differ between subjects, the span
over which they differ is small compared to the range of values expected in healthy subjects
versus patients with PAD. Time to peak perfusion and time to peak T2* both had relatively good
repeatability, and were sensitive to disease presence and severity, making these metrics the
most reliable for detection of alterations in vascular function.

5.5.5. Study limitations
There are several limitations to this study. Some variables have inter-session ICCs of
<0.6, suggesting that the measurement of vascular function by PIVOT during reactive hyperemia
is not suitable for clinical monitoring of a single patient. However, the present method could be
well suited to investigate the response to therapy in a cohort of patients with PAD.
The moderate disease severity group was much larger than either the mild or severe
disease severity groups, though this is less of a limitation when using correlations to investigate
the relationship between disease severity and the MRI-measured variables. Additionally, patients
recruited for this study were not restricted to either aortoiliac or femoropopliteal artery PAD.
Angiographic data were not available for these patients, thus the site of obstruction is not known.
Furthermore, all correlations of the MRI data to disease severity were based on the ABI.
Even though the ABI is the clinical standard for diagnosis of PAD, it is not without limitation. The
ABI may be falsely elevated in patients with severely calcified arteries (158), or in situations of
undiagnosed brachial or subclavian artery stenosis (14). Direct measurement of a patient’s
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functional capacity via exercise testing, including the 100 foot walking time or the claudication
onset time and peak walking time of the Gardner protocol (159), may provide more
physiologically relevant information than the measurement of the ABI alone. However, these
physiologic measures are subjective, based upon an individual’s pain tolerance or effort. There
have been mixed results in prior studies as to whether the physiologic measures of disease
severity correlate with the ABI. McDermott, et al showed that maximum treadmill walking time did
correlate with the ABI (160); however, Szuba, et al found no correlation (161). Assessment of the
correlation between the MRI time course metrics and physiologic testing results would be of great
interest.
The

variables

measured

indicate

impaired

vascular function, related

to

both

macrovascular lesions as well as microvascular dysfunction. Additional measurement of bulk
arterial blood flow during the ischemia-reperfusion paradigm would allow for assessment of
temporal dynamics of blood flow in the macrovasculature and microvasculature. Comparison of
the temporal dynamics in the large artery and capillary bed could help to separate the
macrovascular and microvascular responses. This can be accomplished by velocity-encoding the
multi-echo GRE interleave of PIVOT, though the temporal resolution of the sequence must be
decreased to accommodate double the number of phase encoding segments of the multi-echo
GRE (162). Additionally, the MRI data may be complemented with the measurement of
hemoglobin oxygen saturation using continuous-wave near infrared spectroscopy (NIRS)
(163,164).

5.6. Conclusions
In conclusion, earlier studies investigating peripheral vascular function in patients with
PAD were limited to the investigation of only one or two variables. Using PIVOT, simultaneous
measurement of perfusion, SvO2, and T2* can be achieved. Results indicate that increasing PAD
disease severity is associated with a prolongation of response time following induced ischemia.
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Time to peak perfusion and time to peak T2* were both highly repeatable measures and were
sensitive to the presence and severity of PAD. In the future, PIVOT could be used as a means to
monitor disease progression and evaluate treatment response in patients with PAD.
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CHAPTER 6: CONCLUSIONS AND FUTURE WORK
6.1. Conclusions
The regulation of blood flow to skeletal muscle remains an active area of research,
despite the fact that early work was conducted almost 100 years ago. Work progressed from the
assessment of blood flow in individual capillaries through the quantitative measurement of flow
and oxygenation in vivo. Applications assessing vascular reactivity and the regulation of blood
flow in healthy individual enhanced the knowledge of normal physiology, and investigations in
states of disease have provided insight into the consequences of endothelial dysfunction.
To that end, the work in this thesis has focused on the development, evaluation,
expansion, and clinical application of an MRI method to assess vascular function in humans. In
Chapter 2, the PIVOT method was introduced for the measurement of temporally-resolved
perfusion, SvO2, and T2*. PIVOT was initially evaluated in comparison to the individual
components of the sequence: a PASL interleave for the quantification of perfusion; and a multiecho GRE sequence for the measurement of SvO2 from the evolution of the signal phase and for
the measurement of T2* from the measured magnitude signal decay rate. In healthy subjects,
PIVOT and comparison sequences were used to measure the reactive hyperemia response, and
results showed that no bias existed between the combined and individual measurements. Neither
the magnitude nor the timing of the reactive hyperemia response was found to significantly differ
between PIVOT and the individual methods. However, the maximum post-ischemia perfusion was
lower than previous reports, which led us to the pursuit of Chapter 3.
In Chapter 3, internal consistency of the reactive hyperemia perfusion response was
assessed between PASL and pCASL. pCASL is a more recently developed technique that has
been purported as the preferred method for investigation of perfusion in the brain. Similar to
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CASL, pCASL inverts inflowing spins using flow-driven adiabatic inversion, which has not been
specifically evaluated in the peripheral circulation. Given the difference in the flow waveform
characteristics between the central and peripheral circulation, and given the wide range of blood
flow velocities experienced in the peripheral circulation during a reactive hyperemia paradigm,
this merited specific investigation. pCASL labeling efficiency was experimentally measured in the
popliteal artery throughout an ischemia-reperfusion paradigm. Results suggest that despite the
variation in average flow velocity throughout the paradigm, labeling efficiency may not change.
Reactive hyperemia perfusion was then quantified with PASL and pCASL sequences and results
were not found to significantly differ despite the differences in labeling method, perfusion
quantification model, and temporal resolution.
In Chapter 4, the original PIVOT sequence was expanded to include an OxFlow
interleave after the PASL acquisition. This third interleaved slice provides a proximal measure of
arterial and venous bulk blood flow as well as an additional measurement of SvO2 in a larger
draining vein. The new sequence was termed vPIVOT and was applied to the measurement of
transient changes of blood flow and oxygen saturation both in the post-ischemia reactive
hyperemia and post-exercise functional hyperemia states. Reactive hyperemia results were again
compared between the adapted vPIVOT sequence and independent measures using either
PIVOT or OxFlow. The reactive hyperemia dynamics were not found to differ depending on the
acquisition sequence. The measurement of vPIVOT during the post-exercise period of functional
hyperemia allowed for the investigation of muscle oxygen consumption (𝑉𝑂! ). With vPIVOT, 𝑉𝑂!
was measured as the product of draining vein SvO2 and either muscle mass-normalized bulk
arterial blood flow or local tissue perfusion. Although the total oxygen consumption was not
different between the two measures, the response dynamics including the timing of the maximum
and the peak magnitude were significantly different.
Finally, in Chapter 5, we applied the original PIVOT sequence described in Chapter 2 in a
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cohort of patients with PAD and healthy controls. Results, in agreement with prior independent
studies of perfusion, SvO2, and skeletal muscle T2*, showed that compared to healthy controls,
patients had a blunted and delayed hyperemic response. Furthermore, correlations between the
clinical measurement of disease severity, the ABI, and the timing of the reactive hyperemia
response were detected. Specifically, patients with a lower ABI had: 1) a more delayed reactive
hyperemia response time, manifesting as an increase in time to peak perfusion in the
gastrocnemius, soleus, and peroneus muscles, and in the anterior compartment; 2) an increase
in the time to peak T2* measured in the soleus muscle; and 3) a prolongation of the posterior tibial
vein SvO2 washout time. These results suggest that PIVOT may be a useful tool to investigate
the pathophysiology of PAD and potentially response to therapy.

6.2. Future Directions
If I’ve learned anything in my time as a graduate student, it’s that answering one question leaves
you asking more. Based on the results presented in this dissertation, several issues could benefit
from further investigation:

6.2.1. Technical Development
Dual acquisition for ASL and BOLD measurement: Presently in PIVOT, T2* is quantified
at the downstream slice location, generally located at the distal extent of the gastrocnemius
muscle. Thus, T2* was quantified in the soleus muscle, whose central location and larger crosssectional area provided better data. However, as described in the introduction there have been
several recent studies using a dual echo EPI acquisition to measure the combined ASL and
BOLD responses: the first echo with short echo time is used for perfusion quantification, and the
second echo with longer echo time is sensitive to BOLD signal changes. PIVOT could be adapted
to include a dual-echo readout, which would allow the measurement of the BOLD response in all
muscles of the calf and furthermore would provide direct spatial correspondence between the
perfusion and BOLD data.
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Improved temporal/spatial resolution of MR susceptometry-based oximetry: Given
the limited time of the ASL post-labeling delay, a view sharing technique was required to allow the
limited data acquired during the dynamic acquisition to be reconstructed at high enough spatial
resolution. However, for keyhole acquisition and reconstruction, exact anatomic correspondence
must be maintained between the dynamically acquired data and the reference image acquisitions.
Cuff-induced motion notwithstanding, it can be very difficult for clinical patients to remain still for a
13 minute scan. The use of more advanced view sharing techniques would allow for more
tolerance to patient motion. These include BRISK, in which a slightly smaller segment of the
central portion of k-space is acquired dynamically and outer k-space is periodically acquired.
Rodgers, et al employed BRISK sampling in OxFlow showed improved motion sensitivity
compared to keyhole acquisition (165). Alternatively, the use of parallel imaging methods could
increase the speed of acquisition, thus reducing the number of missing k-space lines.

6.2.2. Technical investigations
Comparison between T2’-based oximetry and susceptometry-based oximetry: As
discussed in Chapter 4, draining vein venous oxygen saturation is not synchronized with the
tissue oxygen saturation in post-ischemia evaluations, but rather the measured washout of
deoxygenated blood is the aggregate from the previous period of ischemia. This is one of the
reasons why 𝑉𝑂! was not calculated for any of the reactive hyperemia experiments. There is no
physical barrier between the capillary bed and the draining vein in exercise, and in fact the
rhythmic contractions help to drive the venous flow, thus in the post-exercise functional
hyperemia state, we assumed that the draining vein SvO2 was equivalent to the local capillary
bed oxygen saturation.

However, given the discrepancy between the macrovascular and

microvascular flow responses during the post-exercise functional hyperemic period, there may
also be differences between the macro- and microvascular oxygen saturation. The combined
assessment with BOLD may help to elucidate this issue, however the direct comparison to a T2’-
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based method would help to directly answer the question. This could be investigated by
comparing post-exercise SvO2 dynamics in the draining vein measured via susceptometry-based
oximetry to the capillary bed oxygen saturation measured via the SAGE technique used by Buck,
et al (116).

6.2.3. Additional Clinical Translation
Presently, measurement of ABI and physiologic testing via standardized treadmill walking
tests are used to assess response to intervention and disease progression. ABI, however, may
not change due to exercise intervention despite improvements in patient symptomatology.
Therefore, the development and investigation of a non-invasive, subject effort-independent
method to assess vascular function is highly desirable. In the future, reactive hyperemia response
dynamics measured with PIVOT could potentially be used as a biomarker for disease progression
and response to therapeutic intervention. In fact, progress is already being made toward
investigating the potential of PIVOT to detect a treatment response. Building upon the study
described in Chapter 5, 136 patients with PAD were scanned at baseline, randomized into either
a supervised exercise rehabilitation (SER) program or standard medical care (SMC), and then
returned for an identical follow-up visit after three months of intervention (Figure 6.1). The
patients randomized to SMC continued their medical management as prescribed by their primary
care physician or cardiologist, and those randomized to SER additionally met with a personal
trainer and exercised three times per week for a period of approximately three months.
The baseline and follow-up visits both consisted of a physiologic testing session as well
as a reactive hyperemia MRI scan. Physiologic testing involved a treadmill-walking test using the
Gardner protocol, which requires patients to walk on a treadmill at 2 mph initially with 0% incline
and the incline is increased by 2% every 2 minutes. Patients indicate to study coordinators when
they first experience pain (claudication onset time, COT), and when the pain limits their ability to
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walk (peak walking time, PWT). For the reactive hyperemia scan, PIVOT was used to investigate
the vascular function as described in Chapters 2 and 5.

Figure 6.1. Study design for patients recruited to participate. Following screening
and baseline testing visits, each patient was randomized into either supervised
exercise rehabilitation or standard medical care. All patients returned for a followup testing visit approximately 3-4 months after his or her baseline testing visit.

112/136 patients returned for their follow-up visit 119±28 days after the baseline visit (19
lost to follow-up, 5 presently enrolled). From the initial testing visit, significant correlations were
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detected between ABI and reactive hyperemia response time across all patients, however no
correlation was observed between ABI and reactive hyperemia response magnitude or between
ABI and indices of functional disease impairment measured by treadmill-walking test (Figure 6.2).
From baseline to follow-up, COT and PWT significantly increased in the SER group (paired t-test,
p<0.0001 for both). COT significantly increased in the SMC group as well (paired t-test, p<0.01).
From the MRI data, no significant differences were detected between the SER and SMC groups
at baseline or follow-up for any metric. In the SER group, the change in peak perfusion between
baseline and follow-up significantly increased in the peroneus (p<0.05) and when averaged
across the whole leg (p<0.05) (Figure 6.3).
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Figure 6.2. Correlation plots between treadmill-walking test and disease severity
as assessed by ABI (a-b) and MRI-measured reactive hyperemia response
metrics and ABI (c-h). Significant correlations exist between ABI and reactive
hyperemia response time (e.g. time to peak perfusion, SvO2 washout time, and
time to peak T2*).
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Figure 6.3. Average measurements at baseline and follow-up for SMC (solid)
and SER (striped). Error bars represent standard error. * indicates significant
difference between SMC and SER groups (unpaired t-test), † significant withingroup difference between baseline and follow-up (paired t-test). All of the
significant differences observed are displayed.

This preliminary analysis showed that patients enrolled in a supervised exercise
intervention had a significant increase in peak perfusion in the peroneus and across the entire
cross-section of the leg. This response may be attributed to increased angiogenesis induced by
exercise, however additional studies are needed to investigate that hypothesis. Moreover, since
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the reactive hyperemia response time is highly correlated with ABI as seen in Figure 6.2 (which
is primarily a marker of macrovascular disease), it may make sense that changes in response
time are not observed since the stenoses, which are responsible for reducing the ABI, are
relatively fixed. Future analyses will explore whether changes in the MRI-measures of vascular
function are correlated with changes in physiologic response as measured by the treadmillwalking tests, blood markers of angiogenesis, and patient quality of life questionnaires.
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